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PART A 
INTRODUCTION 

Chapter 1 
iNFECTiON-PREVENTION IN THE ICU 
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1.1 Introduction 
lifesupporting techniques in the intensive care unit (ICU) are responsable for the 
growing number of technically difficult procedures in increasingly older patients 
but can be detrimental to general defences in these critically ill patients. Major 
surgical procedures necessitating postoperative intensive care including haemo-
dynamic support, monitoring and mechanical ventilation are therefore frequently 
complicated by nosocomial infections, which are defined as infections acquired 
in the hospital environment and predominantly caused by gram-negative hospital 
bacilli. Therapy of these gram-negative infections is difficult and shows a 
substantial failure-rate which contributes to the associated morbidity and 
mortality. Critical care and infection-prevention must be inseparable and 
intertwined for these reasons. 
Until only one decade ago nosocomial infections were thought to origi-
nate mostly from exogenous sources such as hands of personnel, invasive 
procedures and the inanimate environment. Much effort was taken to prevent 
these infections by rigorous isolation- and barrier nursing techniques, strict 
hygienic- and handwashing protocols next to the restrictive use of antibiotics 
genera!ly advocated in order to prevent an increase in resistant micro-organisms. 
Handwashing discipline is however poor1•2 , and isolation has little effect3 , is 
time-consuming and labour-intensive4 • Even when these preventive guidelines 
were followed vigorously and adequate, infections continued to be a major 
threat to those critically ill patients', illustrated by infection-rates up to 70%~'­
This made Haley' conclude that only approximately 32% of nosocomial infec-
tions were potentially preventable by infection-prevention programmes, and 
MakP" that apparently the inanimate environment had no major contribution to 
nosocomial infection. Already in the sixties Ravin et al. 10 described the gut as an 
origin of bacteria and endotoxins causing illness, but it was not until the 
seventies that more attention was focused to the patients own microflora as an 
important endogenous reservoir of infection. This reservoir of micro-organisms is 
however closely interrelated with the environment since "patients are bacterio-
logic chameleons who assume the flora of their surroundings"11 • Several 
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ambitious prophylactic regimes emerged to eliminate this pool of micro-orga-
nisms, but many failed because resistance and superinfections resulted. 
Selective decontamination tSD) is presented by van der Waay as a novel 
way of ·antibiotic prophylaxis which restores or enhances colonization resis-
tance, thereby preventing the more serious gram-negative infections without 
endangering the hospital environment. For that purpose enteric non-absorbable 
antibiotics are used in such doses that high intraluminal concentrations in the 
gut are reached. Consequently, these concentrations are well above the minimal 
inhibitory concentration {M!C) of most aerobic gram-negative micro-organisms, 
which minimizes the risk on the emergence of resistance within this bacterial 
reservoir. Another advantage in this respect is that those non-absorbable 
antibiotics used in this regime do not reach tissue levels adequate to treat deep 
organ infections, so they are not in general use in the hospital which again 
minimizes the danger of developing resistance. 
On first sight, this concept looks promising because the more serious gram-
negative infections are prevented without causing an increase in resistance. One 
of the problems in proving the efficacy of selective decontamination is however 
the use of systemic antibiotics during the first days in the originally described 
regimen 12 • The reduction in the number of lower respiratory tract infections only 
reached statistical significance when systemic antibiotics were added to the 
original enteral regime, which is in fact in contradiction to the concept of 
selective decontamination. In view of this finding, it is important to know that 
many infections in the ICU will evolve early during the patients admittance 1 :~., 6 , 
so using systemic antibiotics in this period could be therapeutic in occult 
infections, and could give a distorted view of the "prophylactic" effects of 
selective decontamination16.17 • !n addition, especially the diagnosis of pneumonia 
is difficult to assess in critically ill patients. These factors together make the 
contribution of systemic antibiotics unclear and the results of selective decon-
tamination difficult to interpret. 
It also seems likely that infections will lead to excess mortality, prolonged 
hospitalisation and increase in cost of care. As a result of decreased infection 
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rates by implementing a prophylactic regime, one would therefore expect to see 
a decrease in the infection-related mortality. Still, it will be very difficult to 
detect such a difference, reminding that the infection-related mortality is not 
easy to disentangle from overall mortality in heterogeneous groups of critically ill 
patients with several potential causes of death. In agreement with this, Gross et 
al. 18 and Bryan and colleagues" thought that only patients admitted with curable 
diseases would truly benefit from infection-prevention and -control programmes. 
Consequently, it will be unreasonable to address the absence of an anticipated 
mortality-effect to the failure of any intervention in studies using mixed patient-
groups. The best study-population would be the one with high risk to develop 
infections but with low intrinsic risk of dying due to underlying disease. 
Until recent years, no randomised studies to the effects of selective decontami-
nation on colonization- or infection-rates were available. The lack of concurrent 
controls, the heterogeneous mixture of patients and intensive care units, and 
the absence of consensus in the diagnosis and definitions of infections further-
more precluded a valuable evaluation. To solve this issue we identified the 
group of patients admitted for oesophageal resection because of carcinoma as a 
homogeneous group eligible for the purposes of this study. This would restrict 
conclusions to that patient-group only, but should have increased validity and 
power concerning effects of selective decontamination on gram-negative 
colonization- and infection-rates. The elective setting in these patients raised the 
possibility to restrict the use of systemic antibiotics only to the pre-operative 
days during which selective decontamination is installed. This would be advan-
tageous both in study-design (no influence of systemic antibiotics on post-
operative nosocomial infections) and in decreasing antibiotic pressure in the ICU 
(and concern for the hospital epidemiology). 
In the successive cohort-study the efficacy of selective decontamination 
was studied with respect to morbidity and mortality, knowing that the relation 
between infections and death is an intimate one. We recognised a considerable 
amount of failures of decontamination within the group of ICU-patients receiving 
SO-medication, and thought these failures (with ineffective infection prevention) 
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could be responsible for excess (infection related) mortality within the total 
group of patients receiving this prophylaxis. We thought this group could be 
responsible for possible unmeasured effects of selective decontamination on 
mortality. In addition, possible adverse effects of SD on the hospital-flora and 
the process of rebound colonization after the transfer of patients to the ward 
were evaluated. 
1.2 Patient population 
Patients admitted to have an oesophageal resection because of carcinoma 
belong to a group of high risk patients who easily develop pulmonary tract 
infections. This is partly due to the operation itself, as a result of which the 
normal anatomy is disturbed and regurgitation and aspiration of gastro-intestinal 
contents can easily occur. The upper abdomina! and thoracic incisions can 
furthermore result in insufficient respiration and coughing during the first 
postoperative days, causing atelectasis and possible pulmonary infiltration. This 
in combination with the infection-risk on the surgical ICU in general6 accounts 
for the 20% pulmonary tract infections in the 60 patients operated yearly. 
Bearing this in mind, it seemed logical to try to see whether the concept of 
selective decontamination would be of value in this homogeneous group of 
patients with serious disturbances of their colonization resistance. Moreover, 
these patients undergo a standardised trauma and are all postoperatively 
transferred to the surgical lCU for mechanical ventilation. 
The descriptive cohort study evaluates the process and efficacy of 
selective decontamination in all patients receiving this prophylaxis. Based on the 
results of the preceding prospective randomised study, selective decontamina-
tion was institutionalised in all patients with high risk on pulmonary tract 
infections undergoing any major surgical procedure. Moreover, existing literature 
at that time suggested that patients with multiple trauma might also benefit 
from this prophylaxis. These two groups constituted the majority of patients in 
the successive study. 
1.3 Objectives of investigation 
The studies described in this thesis aim to answer the following questions: 
does selective decontamination cause 
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1. a reduction of the number of respiratory tract infections in patients 
after oesophageal resection? 
2. a reduction or disappearance of potentially pathogenic micro-
organisms? 
3. a reduction of mortality? 
4. increased resistance to antibiotics? 
5. any adverse effects when discontinuated? 
1.4 Outline of the thesis 
In Part A the extent of the problems in infection-prevention is described in 
Chapter 1 and nosocomial infections are defined in Chapter 2, in which also the 
difficulties of infection diagnosis in critically ill patients are reviewed. Chapter 3 
describes the history of antibiotic prophylaxis in surgery, the development and 
theory of selective decontamination and a review of published trials. 
In the second part (Part B), original studies to the clinical effect of 
selective decontamination on gram-negative infections (Chapter 4) and coloniza-
tion (Chapter 5) are presented. An analysis of the mortality-effects is given in 
Chapter 6, while Chapter 7 deals with the consequences of recolonization and 
possible resistance after withdrawal of this prophylaxis. Results are integrated in 
the general discussion in Chapter 8. References to the literature are given at the 
end of each chapter. 
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2.1 Introduction 
Nosocomial infections are those infections acquired within the hospital and mostly 
caused by aerobic gram-negative micro-organisms, although the increasingly 
multiresistant Staphylococcus aureus and Enterococcus sp are becoming more 
important as etiologic agents in present-day medicine1·2 • For diagnostic purposes 
most studies arbitrarily define these infections as emerging after 48 hours of 
admission, whereas the Centers for Disease Control3 (CDC) demands "no evidence 
of infection present or incubating upon hospitalisation", thereby deliberately 
opposing to time-determinations. According to these CDC-guidelines, the diagnosis 
of infection can be made on clinical grounds, but almost always needs supportive 
evidence from subsequent diagnostic procedures. When these data are absent, 
"the empirical initiation of appropriate antibiotic therapy" is crucial to accept the 
present symptoms to be the consequence of an infection. 
Nosocomial infections occur in 5-10% of all hospital admissions, and are at 
least contributory in approximately 59% of hospital deaths; while most deaths 
occur on the medical ward, 25% of deaths on the medical and 50% on the surgical 
service are associated with infection•. The incidence is dependent on the hospital, 
ward or patient-population studied, and several studies indicated that the surgical 
ward and intensive care unit harbour the greatest risk to acquire nosocomial 
infections5"6 • Surgical patients represent 41% of the admissions but experience 
71% of all nosocomial infections distributed through the various sites shown in 
Table 2.1; they have a 14% risk to develop a pneumonia compared to a 3% risk 
in all admissions'. Particularly the intensive care unit (ICU) which comprises only 
8% of all hospital beds knows a five· to tenfold incidence compared to normal 
wards7 -s and harbours 33 to 45% of nosocomial infections (Table 2.1). This is 
probably due to the high number of extremely vulnerable, critically ill patients, and 
the widespread use of invasive devices9 • Again, surgical patients are at high risk4·10 
since the surgica!ICU shows 35 infections per 100 admissions compared to 14 on 
the medicaiiCU11 • Up to 70% of the patients in a surgica!ICU have gram-negative 
infections after 7 days of admission12 , increasing the mortality to 60% 10•13. 
Because of the high antibiotic pressure in the surgical ICU14, a relatively high 
24 
contribution of "epidemicn infection due to (more and more intrinsically) antibiotic-
resistant micro-organisms10•15 is increasingly encountered. 
Table 2.1 Site of nosocomial infection in surgical patients and lCU 
Urinary tract 
Wound 
Respiratory tract 
Blood (Septicemia) 
After Haley5 and Weinstein 1/.1 
Frequency of invofvement !%) 
Surgical patients6 
42 
40 
14 
4 
24 
8 
31 
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The impact on socio-economic resources is enormously; nosocomial 
infections prolong the hospital stay with 3 to 4,5 days per infection and increase 
the costs with approximately 590 (19761 US-dollars17• In order to prevent these 
nosocomial infections, it is crucial to understand the pathogenesis and to detect 
risk-factors which predispose to these infections out of the huge amount of 
epidemiological information. For nosocomial infections in general, Craven and 
colleagues" identified days in the ICU, shock on admission, admission to the 
surgical ICU, renal failure and the use of chemotherapeuticals or steroids as risk-
factors, Paries et al.18 furthermore identified age above 50 and higher scores in the 
"Injury Severity Score" (ISS) to be correlated with higher infection-rates. The 
factors strongly associated with fatality were renal failure and the use of 
chemotherapeuticals or steroids, but also the acute physiology score, respiratory 
failure, coma, infection on admission, neurological illness and nosocomial intra-
abdominal infection. 
The following paragraphs will deal with the description of diagnostic 
procedures and pitfalls for each category of infection. 
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2.2 Pneumonia 
Epidemiology and etiology 
The incidence of nosocomial pneumonia is an overall 0,5 to 5% when all hospital 
admissions are regarded"·" which matches 8,6 episodes per 1000 admissions" 
ranging from 3,6 in non-teaching hospitals to 10,6 on surgical wards of teaching 
hospitals". The incidence again depends on the population studied; ICU-admitted 
patients have a 4 to 21 fold incidence compared to those on the ward 6'20 , which 
is the reason why 41% of all pneumonia's occur in the !CU6 • Within this group of 
!CU-patients the risk to develop a pneumonia increases from 12 % in those in the 
medicaiiCU" to 22% in a mixed medico-surgicaiiCU" and 31% in patients in the 
surgicat ICUe.H>·,,. Compared to patients without respiratory support, intubated 
patients have a 6 to 20 fold increase in pneumonia-rates which can rise up to 
70%26-26, while each extra day on the ventilator increases the risk to develop a 
pneumonia with an additional 1 %27 • Respiratory tract infections are responsible for 
an excess stay of 5 to 7 days5·21 in all patients, or more than 9 days in survivors 
as seen in a case-matched study28 • 
The mortality-rate in ICU-patients with a pneumonia is 42% compared to 12% in 
those without one29 • Nosocomial pneumonia accounts for at least 15% of all 
hospital deaths" and is therefore the principal cause for infection-related mortality 
in the hospital. Fatality rates range from 30% in mechanically ventilated patients30 
to 60% in patients who are admitted with respiratory failure due to a pneumonia24 . 
These fatality rates are related to the causative micro-organisms (Table 2.2); high 
risk microbes are Pseudomonas sp, S.aureus and Enterobacteriaceae"·" but most 
pneumonia's are po!ymicrobial 2z.z3.31 with a mortality rate of 67% 25• Of interest in 
this regard is that Craig and co-workers" identified Pseudomonas sp, when causing 
a pneumonia, as an independent risk-factor for mortality. 
Risk-factors 
Risk-factors for pneumonia, determined by multivariate analysis or stepwise logistic 
regression techniques include the presence of general conditions as chronic 
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Table 2.2 Frequency of isolated pathogens 
in nosocomial pneumonia. 
Pseudomonas sp 17 
Staphylococcus aureus 1 3 
Klebsiel!a sp 12 
Enterobacter sp 9 
Escherichia coli 6 
Serratia sp 6 
Proteus sp 4 
Modified from Scheld22 
obstructive pulmonary disease (COPD)", age above 70"·" and smoking'. Surgically 
induced risk factors are thoracic or upper abdominal incisionsll·26 and whether an 
emergency-operation was performed 29 • Diminished consciousness and high 
volumina aspiration are additional factors, whereas the presence of ventilation or 
intubation alone25'31 or ventilation for more than either 2429 or 72 hours30 represent 
an independent risk. Respiratory therapy would result in a 4 to 66 fold risk", but 
according to Langer26 this would only be contributory. Emergency intubation32 or 
reintubation30 , frequent ventilator change as well as the presence of an intracranial 
pressure monitoring device3 , are other risk factors. The use of positive end 
expiratory pressure ventilation (PEEP) was found to be nearly significant as a risk 
factor". Additional risk factors tor staphylococcal pneumonia are the presence of 
coma and COPD". 
Pneumonia is an independent risk factor for fatality when occurring in critically ill 
patients such as those with abdominal sepsis", although this could not be 
confirmed in another study". When pneumonia is already acquired, the following 
risk factors are correlated with fatality: age above 60, underlying condition, ICU-
admittance and ventilation 10, inappropriate antibiotic therapy, respiratory failure30, 
bilateral pneumonia on plain chest film 26, longer time period to develop the 
pneumonia21 '26 , preceding ventilation-period, rapidly or ultimately fatal disease21 and 
septic shock". A high risk micro-organism causing the pneumonia was identified 
as an independent risk factor for fatality", but this could not be confirmed by 
another study''. 
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Pathogenesis 
Micro-organisms causing pneumonia can be acquired by aspiration, by air or 
haematogenous spread. While the latter two seem to be far less common 14'32 , the 
one important factor in sequelae preceding pneumonia seems to be oropharyngeal 
co!onization 23•36 and the aspiration of these contaminated secretions. Oropharyngeal 
colonization is enhanced by illness or immunosuppression36"37 , endotracheal 
intubation, coma, hypotension, acidosis23 , length of admission 3a-39, advanced age40 , 
number of invasive procedureS13' 39-4°, and the use of immunosuppressive agents or 
antibiotics23'41 • The microbial property to adhere to epithelial cells is amongst others 
related to the function of fibronectin, an epithelial glycoprotein covering epithelial 
receptor sites, which is also reduced with illness and after operations42• Micro-
organisms could even show preference to tracheal cel!s and can thus cause 
pneumonia without showing significant colonization of the oropharynX43• 
Acquisition of oropharyngeal micro-organisms by retrograde colonization 
from the stomach (endogenous colonization) has been described to be enhanced 
by the presence of nasogastric tubes and the supine position through an increase 
in gastric refiUX31 '44-45 • The influence of gastric pH and subsequent colonization of 
stomach contents on oropharyngeal or tracheal colonization is repeatedly 
described'"'' but the role of stress-ulcer prophylaxis in the pathogenesis of 
pneumonia is under much debate. Several authors reported the detrimental effect 
of H2 -antagonists and antacids on the rate of pneumonia by increasing pH 48-50 • 
Eddlestone and co-workers51 found a positive effect of sucra!fate on pneumonia 
rates, but whether this effect occurs as a direct antibacterial effect or as a pH 
effect is still unanswered despite several meta-analyses20.&2. Cook et aL could not 
confirm an effect of H2-blockers or antacids on the incidence of pneumonia in their 
meta-analysis52 • Others denied the relation between gastric colonization and 
pneumonia 53 or could not confirm it20' 54 • Moreover, in the A pte study-Ei0 only 56% of 
ranitidine treated patients versus 44% of controls showed isolation of the same 
micro-organism in gastric contents and specimen obtained during the subsequent 
pneumonia. Finally, Fiddian-Green" thought translocation of micro-organisms 
through the stomach wall could be causally more important since intra mucosal pH 
was a better predictor for pneumonia in their study. 
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Table 2.3 
Garibaldi 1981 6 
Class 1 
Class 2 
Class 3 
Oriks. 198749 
Definitions of nosocomial pneumonia 
Microbiologically proven pneumonia 
Clinically apparent, no bacteriological evidence 
Fever, purulent sputum, suggestive radiographic findings 
New infiltrate on plain chest film, and at least three of the following criteria 
in ventilated patients: 
1: Purulent sputum 
2: Important nosocomial pathogen in culture of tracheal aspirate 
3: Leucocytosis > 1 0.000/mm:> 
4: Temperature > 38"C 
Garner ICDCJ 19883 
One of the following criteria: 
1: Pneumonia on physical examination and any of: 
a: New purulent or change in sputum 
b: Positive blood culture 
c: Pathogen in tracheal aspirate, bronchial brush or biopsy 
2: Pneumonia on plain chest film and any of: 
a: In combination with 1.a-c as above 
b: Virus or viral antigen detected 
c: Serologic evidence of infection 
d: Histologic evidence of infection 
Celis, 198826 
New infiltrate on plain chest fi!m, not otherwise explained, and combination 
of the following: 
1: Temperature > 38"C 
2: Leucocytosis > 1 O.OOO/mm3 
3: Cough and purulent sputum, bacteria on gram-stain with > 25 
polymorphonuclear leucocytes and < 1 0 epithelial cells per 
high power field. 
Modified from Goldman63 
Diagnosis 
There is no gold standard for the diagnosis of pneumonia, which is mostly defined 
according to various combinations of clinical, radiological and laboratory findings. 
It is often suspected, but also easily missed as appeared from post-mortem 
analyses in the adult respiratory distress syndrome (ARDS) 55 • CDC-definitions 
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involve typical findings on physical examination and/or chest X-ray and the new 
onset of purulent sputum, an organism isolated from specimen obtained by 
transtracheal aspirate, bronchial brushing or biopsy as well as in blood-cultures. 
Without clinical or radiological evidence of pneumonia, these signs are considered 
to be the consequence of (tracheo-)bronchitis". 
Interpretation of clinical and radiological findings is however difficult22 and 
often not reproducible, resulting in a wide range of definitions (Table 2.3L 
incidence rates and much debate. Even the positive response to antibiotic 
treatment as a clinical indicator of pneumonia is not conclusive for the diagnosis, 
because both patients with and without a pneumonia showed improvement in a 
(postmortem) study56 . Since only 6% of all patients with a pneumonia have 
positive blood-cultures22, most authors feel that the use of these in the diagnosis 
of pneumonia (as proposed by the CDC) is less valid. Transpleural biopsy or needle-
aspiration especially in mechanically ventilated patients is too dangerous to be in 
widespread use57 . Thls resulted in the increased weight given to bacteriological 
isolation of micro-organisms in sputum, but these specimen are difficult to obtain 
in non-intubated patients and otherwise often contaminated with ffora from the 
more proximal airways as appeared [n baboons58 . The isolation of a given micro-
organism is furthermore not solely indicative for a pneumonia but can also mean 
colonization without an infection being present, although the absence of growth 
is a strong argument against pneumonia22 . Attempts to improve the predictive 
value of sputum-samples include transtracheal aspiration, protected brush 
specimen (PBS) and broncho-alveolar lavage (BAL). Tracheal aspirates have 
acceptable sensitivity but show false-positive results in 21% and even up to 85% 
of patients with COPD58, although others found results comparable to PBS59 • 
Specimen obtained by bronchoscopy often show contaminants but by using a 
protected wedge catheter or brush the specificity is improved to 80 and 100%31 
and close to that of BAL30, unless prior antibiotic therapy has been given. Although 
BALis easier than PBS and samples a wider area, both diagnostic procedures (with 
sensitivities between 60 and 90%20·31 ) are difficult to perform in the ICU. 
The use of quantitative cultures in the diagnosis of pneumonia is under much 
debate, because a threshold of 103 or 105 CFU/ml in specimen obtained by PBS or 
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BAL is not unanimously accepted57, and will implicate that the pneumonia is 
already full-blown60 and therefore difficult to treat. On the other hand, some 
patients with proven pneumonia can show only low bacterial counts and will 
therefore not be treated, whereas others without one can have higher counts and 
as a result be treated as having a pneumonia61 • Finally, residual quantities of 
antimicrobials can remain in the bronchial tree62 and can therefore prevent growth 
in samples ("carry-over" effect), reason why some advocate diluting these effects 
by washing of samples. 
Irrespective of the difficulties, one should not only rely on clinical symptoms 
but search for further confirmation in the need for quick and accurate diagnosis of 
pneumonia. 
2.3 Wound-infection 
Epidemiology and etiology 
The main problem in establishing the incidence of wound infections is that up to 
75% of the wound problems become evident after the discharge of patients6""64• 
Nevertheless, rates from 5 to 20% are reported with 17% of these infections 
occurring in the ICU8 . Haley65 found a frequency of 29%, but also thought them 
responsible tor 57% of excess costs and 42% of the excess stay related to 
nosocomial infections; Nichols66 thought these infections responsible for doubling 
the duration of stay. 
A worthwhile evaluation of wound infections must include the different 
subgroups of wound-classes (Table 2.4) 67 because percentages rise from 1.5% in 
class 1 to 40% in class 4. Class 1 wounds are said to reflect "surgical care" 
because all infections in this group are the result of exogenous factors by the 
absence of endogenous contamination68 . Any wound infection rate exceeding 2% 
in this group of wounds is therefore reason for self-reflection although many 
studies report higher rates. Next to the nosocomial gram-negative bacteria, an 
increasing number of gram-positive micro-organisms are recognised as etiologic 
agents66 . 
Table 2.4 Wound-class 
1. Clean: 
Gastro-intestinal tract is not opened, no inflammation and no break in aseptic 
technique is encountered (including cholecystectomy, appendectomy and 
hysterectomy without inflammation). 
2. Clean contaminated: 
Clean operation, with opening of the gastro-intestinal tract but without spillage. 
3. Contaminated: 
Acute inflammation without pus, or spillage of contents from the gastro-
intestinal tract is encountered. "Fresh" traumatic wounds and procedures with 
a major break in asepsis are included. 
4. .Qlny: 
Procedures in which pus or a perforated viscus is found, including afso "ofd" 
traumatic wounds. 
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Pathogenesis and risk factors 
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Risk factors for wound infections are reducible to host factors, exogenous and 
endogenous contamination. They include increasing age, obesity, nutritional status 
and local wound factors, length of pre-operative admission (each extra week 
doubles the incidence), pre-operative shaving of the operation site, length of 
operation (each extra hour doubles the percentage whereas the effect of antibiotics 
is reduced), operation-technique, "breaks" in this technique and wound-class (Table 
2.4)66·69 . Another infection present is also a risk factor for wound infection, but the 
effect is reduced when therapy for this infection is installed at least 24 hours 
before surgery". The prophylactic administration of systemic antibiotics is probably 
most effective when given between 0 and 2 hours before surgery70 and must be 
chosen according to the nature of the procedure and micro-organisms expected. 
However, patients who received peri-operative antibiotics and who developed 
postoperative wound infections were likely to have infections with bacteria 
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resistant against the prophylactic agent71 , indicating that prophylactic antibiotics 
should not indiscriminately been given therapeutically in the postoperative period. 
To increase the quality of care, a risk-predictor consisting of wound-class, the 
length of operation and ASA-score (American Society of Anesthesiology) was 
developed by means of multivariate technique and appeared adequate in predicting 
the rate of wound infection69 • Such an index could be very useful in the surveil-
lance of wound infections and in comparing results from different surgeons and 
hospitals in attempting to lower incidences65. 
Diagnosis 
The CDC-guidelines' distinguish incisional and deep wound-infections. An infection 
is incisionat when it is present at the incision site, within 30 days of surgery and 
above the fascial layer, and any of the following: 
1. Purulent drainage from wound or drain (above fascia) 
2. Positive culture from fluid out of primarily closed wound 
3. Surgeon deliberately opening the wound (unless culture is negative) 
A deep infection is present at the operative site within 30 days of surgery without 
an implant or within 1 year when an implant is placed, is located beneath the 
fascial layer and when drainage of pus from beneath the fascia is encountered, the 
wound is deliberately opened because of fever or localised pain, or an abscess is 
spontaneously draining. 
2.4 Urinary tract infection 
Epidemiology and etiology 
Urinary tract infections are responsible for approximately 40% of nosocomial 
infections72-73 , they occur in 2 patients per 100 admissions and 16% of these 
infections are encountered in the ICU . These infections are usual benign but 2 to 
4% of the patients experience a bacteraemia which then results in a case-fatality 
of 13 to 30%74 • There seems to be a slow decrease in the incidence during the last 
decades, maybe as a result of better infection-control and less extensive 
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admissions73 • Especially women are prone to get a urinary tract infection caused 
by rectal flora. 
Pathogenesis and risk factors 
Approximately 75 to 80% of nosocomial bacteriuria is caused by instrumentation 
and catheterisation72·73 . Bacteria are invading mostly intraluminal in men (often as 
a result from cross-infection) and periurethral in women, reason why they are 
susceptible for rectal strains. Bacteria in the urine are found as planktonic growth 
or growing in the biofilm on the catheter. These bacteria form encrustations and 
a biofilm around and on the catheter, thereby protecting themselves against 
antibiotics and rendering urine-samples taken from the catheter not fully reliable. 
Removing a catheter in treating bacteriuria is consequently more realistic than 
giving antibiotics. 
Risk factors are female gender, the duration of catheterisation, absence of 
systemic antibiotics and catheter care viofations73 . 
Diagnosis 
The diagnosis is mostly made on clinical grounds (symptomatic bacteriuria) in 
combination with more than 105 CFU/ml. in a urine sample. When no clinical signs 
are apparent the bacteriuria is called asymptomatic. In addition, the CDC3 demands 
no more than 2 species in the cultures. 
2.5 Septicemia 
Epidemiology and pathogenesis 
Catheter-associated (primary) septicemia occurs in 3 to 7 percent of catheters", 
and is mainly related to the percutaneous insertion procedure, insertion in the 
jugular vein 76 and micro-organisms colon ising the skin around the insertion site75 . 
Most septicemias (41 %) occur in the ICU, which has a rate of bloodstream 
infection 24 times that of the general ward8 . Up to 73 % occurs in the surgical 
ICU, where 5 to 17 % of all patients with multiple devices develop a septicemia, 
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which is therefore regarded as a marker for infection6.The infection rate can also 
be influenced by the dressing, with more infections likely to appear in the group 
with "op-site" opposed to those with just a dry gauze. A drawback of this study 
was however that the groups were heterogeneous, different catheters were used 
and that the "op-site" group included more surgical patients and more subclavian 
catheters77 . New investigations are aimed on increasing the barrier function of the 
skin around the catheter by incorporating cuffs75 or impregnating the catheters 
with silver or antibiotics. 
Overall mortality in gram-negative (secondary) septicemia which is mostly 
caused by Enterobacteriaceae and Pseudomonas sp is 36% while 19% is directly 
attributable to the septicemia. Mortality is dependent on the severity of the 
underlying disease, age and the site of infection78 • When shock is also present, 
mortality rises to 64% (overall) resp. 50% (infection-related). Most of these 
septicemia's are the consequence of urinary tract infections which have a lower 
related mortality opposed to the pneumonia-associated septicemia with a mortality 
up to 72%79 . 
Diagnosis 
CDC-guidelines for primary septicemia include the isolation of the same pathogen 
not related to an infection at another site from at least two b!oodcultures in a 
patient with intravascular access devices. Clinical sepsis additionally includes fever, 
hypotension or oliguria with no other plausible cause. With the inability to culture 
micro-organisms "appropriate antibiotic therapy" must be instituted to meet the 
diagnosis3 . 
35 
2.6 Definitions used in the study 
ColonizatiOn was defined as the isolation of the same micro-organism in two 
consecutive cultures taken from one locus, without clinical signs of infection. 
Recolonization is colonization during the administration of selective decontamina-
tion, rebound colonization as colonization after the withdrawa! of SO-medication. 
Successful decontamination was reached when no PPM were cultured in 
oropharynx or rectum, unsuccessful decontamination was the inability to reach 
decontamination within 3 days or was defined when recolonization with PPM 
occurred. 
Infection was defined as the presence of the following clinical signs: temperature 
above 38' C and characteristic findings at physical examination. When clinically 
suspected, infections were confirmed by radiological, laboratory and bacteriological 
findings: a white cell count of less than 4000 or more than 10.000 lmm', and 
positive cultures from the infected area. 
Primary infections develop within 48 hours of admission and are mostly caused by 
community-acquired gram-positive micro-organisms. Secondary infections, arising 
after 48 hours of hospital admission, are presumed nosocomial and are mostly 
caused by gram-negative micro-organisms. infections preceded by colonization of 
the infected organ-system with the same causative micro-organism are defined as 
endogenous. 
A lower respiratory tract infection is defined when the new onset of purulent 
sputum was present with rales or dulness to percussion. A new infiltrate on a 
chest radiograph had to be seen by an independent radiologist, and cultures from 
bronchoscopic lobular aspirations had to show growth of micro-organisms. A 
urinary tract infection is present when more than 106 bacteria per ml in catheter-
urine are cultured. Septicemia is defined as significant haemodynamic disturbances 
(hypotension, oliguria or anuria) not explained by other causes and positive blood 
cultures; primary septicemia is catheter-associated while secondary septicemia is 
related to other infections in the patient. Every purulent discharge from wounds, 
with a presence of micro-organisms in gram-stains or cultures is considered a 
wound-infection. 
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3.1 Introduction 
The prophylactic use of antibiotics in surgery is mainly concerned with the 
prevention of postoperative wound- and deep infections; it is generally accepted 
as being effective when the proper antibiotic is given in the right dosage for a short 
period around'·' or immediately before' the operation, thereby providing effective 
tissue levels of the drug at the time of surgery. Even patients undergoing clean 
procedures such as herniorrhaphy and breast surgery may benefit from antibiotic 
prophylaxis, as indicated in a large multicenter trial {48% fewer infections 
compared with a placebo-group)'. Not surprisingly, 40% of surgical patients receive 
prophylactic antibiotics, accounting for 30% of alt in-hospital antibiotic use6 • 
Approximately 20 to 30% of all hospital-admitted patients receive antibiotics 
during their stay, but in an inappropriate dose or for an inappropriate duration in 31 
to 52%, and even up to 62% on surgical wards·v-a. Transfer of resistance among 
micro-organisms occurs especially on mucosal surfaces in the digestive tract or on 
the skin'·", and the inappropriate use of antibiotics can be one of the causes of the 
increasing drug-resistance seen in hospital-flora. For that reason each nover 
prophylactic regimen should be adopted only reluctantly in clinical practice, with 
maximal surveillance of the possible development of resistance. 
3.2 Normal flora in the digestive tract 
Colonization of the digestive tract by micro-organisms starts immediately after birth 
and results within weeks in a flora which is almost similar to the flora in adufts11 ; 
the composition of the normal flora is predominantly influenced by diet and drugs. 
The stomach and small intestine are normally sterile or have very low bacterial 
counts while the oropharynx and colon show a huge variety of bacteria. Each 
micro-organism belonging to the indigenous flora can be advantageous or harmful 
to the host, depending on the circumstances. The former by preventing coloniza-
tion mostly synergistic with other members of the indigenous flora, the latter when 
involved in opportunistic infections or delayed-type graft-versus-host disease, or 
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when enhancing virulence of other micro-organisms11-12• The majority of the 
indigenous flora is however constituted by anaerobic micro-organisms which have 
a low pathogenic potential, they occur in concentrations of 107-109 per milliliter 
saliva, and 109-1012 per gram faeces. Furthermore, in the normal population 
Staphylococcus epidermidis harbours the skin and Enterococci the gut11 ·13 . 
Table 3.1 Potentially pathogenic 
micro-organisms (PPM) 
Gram-negative species: 
Escherichia Coli 
KlebsieHa 
Serratia 
Proteus 
Enterobacter 
Citrobacter 
Pseudomonas 
Haemophilus influenzae 
Acinetobacter 
Branhamella catarrhalis 
Neisseria 
Gram-positive species: 
Staphylococcus aureus 
Streptococcus pneumoniae 
Enterococci 
Candida albicans 
Potentially pathogenic micro-orga-
nisms (PPM, Table ll are micro-orga-
nisms which can cause infections 
when the proper conditions are set, 
especially when infection resistance is 
impaired. Some persons are oropha-
ryngeal carriers of Streptococcus 
pneumoniae, Haemophilus inffuenzae 
and Candida albicans, some carry 
Staphylococcus aureus on the skin, in 
the oropharynx and gastro-intestinal 
tract. More than 90% of all healthy 
individuals carry Escherichia coli in the 
gut. All of the above mentioned (com-
munity acquired) micro-organisms can 
cause infections but these have low 
morbidity and mortality13 • 
A very small fraction of healthy persons can carry aerobic gram-negative 
micro-organisms (mostly Enterobacteriaceae), but in such low numbers that 
concentrations do not exceed the detection limit (1 02 micro-organisms/g faeces) 
in cultures. These Enterobacteriaceae are ubiquitous in the hospital environment, 
and frequently colonizing seriously ill patients. Infections caused by these hospital 
acquired micro-organisms, called nosocomial infections, are serious infections with 
high morbidity and mortality; therapy knows a high failure rate. 
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3.3 Colonization and infections; colonization resistance 
Despite progress in modern (ICU)-medicine and surgical technique, efforts to 
prevent nosocomial infections have been disappointing. Control of these life-
threatening complications proves to be complex because on admission more than 
50% of the patients are already colonised with the micro-organisms that 
subsequently cause theirinfection14, and especially the relation between oropharyn-
geal colonization and respiratory tract infections is an intimate one15. 16 , important 
evidence for the endogenous etiology of nosocomial infection 17• In this respect, H2-
blockers can be detrimental to the host by enhancing microbial overgrowth and 
retrograde oropharyngeal colonization as a result of increased pH (chapter 2). 
Figure 3.1 Interaction between PPM and the host, influence of 
antibiotics 
ADMISSION 
I 
Continuous acquisition of Enterobacteriaceae 
Passage of PPM, 
no colonization. 
CR: Colonization resistance 
AB: Broad·spectrum antibiotics 
Reduced Colonization Resistance: 
Continuous colonization. 
Further decrease in CR, 
increase in colonization. 
Gram-negative infections 
ensue. 
When admitted to the hospital, the patient's normal microbial flora may be 
quickly replaced by hospital acquired, aerobic, gram-negative bacilli (colonization), 
which are increasingly antibiotic-multiresistant6·15·18• These potentially pathogenic 
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micro-organisms {PPM) are listed in Table 3.1. Critically ill and immunocompro-
mised patients will be colonized within a short time of admission 15•19 , while healthy 
individuals are hardly ever colonized with aerobic, gram-negative PPM {Fig. 3.1). 
Colonization is augmented by disturbances of host flora20 and is because of the 
above mentioned frequently encountered in lCU-admined patients, in whom several 
risk-factors, described in chapter 2 {pp 27), can be recognised. 
Table 3.2 Factors contributing to colonization resistance 
Integrity of epithelial and mucosa! lining 
Desquamation of epithelial and mucosal cells 
Saliva and mucus 
Secretory immunoglobulin A 
Normal swallow and cough reflexes 
Chewing and peristalsis, normal defecation 
Presence of anaerobic (?) flora in the gut 
After experiments in mice, v.d.Waay et al. 21 introduced the concept of colonization 
resistance. They described the elimination of Enterobacteriaceae from the gut and 
a prolonged prevention of recolonization by these micro-organisms using selective 
oral antibiotics. They considered colonization resistance as the first host-defence 
against colonization with potentially pathogenic micro-organisms, consisting of a 
physiological part {Table 3.2) and a microbiological part, the latter thought to be 
predominantly constituted by the anaerobic flora which oppose aerobic micro-
organisms. This bacterial antagonism occurs mainly by competition for food, but 
also by producing toxic products, lowering oxygen tension and masking of receptor 
sites. The importance of normal indigenous flora was illustrated by Bowden22 and 
Schwann23 in patients with pseudomembranous enterocolitis, in whom they saw 
a rapid cure after the enteral administration of fresh faecal suspension. Others 
confirmed the pivoting role of the anaerobes in colonization resistance, but thought 
a polymicrobial flora could maximize it24·25 . Barza et al.26 studied colonization 
resistance in human volunteers, and while they were able to confirm the 
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devastating effect of broad-spectrum antibiotics on it, they could not prove that 
anaerobic microbes had a role to play in such resistance. Nevertheless, the micro-
bial equilibrium is a dynamic ecosystem which can effectively prevent colonization 
with exogenous strains27• Patients with reduced defense-mechanisms (Table 3.3) 
may benefit from an optimal microbiological part of colonization resistance which 
is unharmed by colonization resistance indifferent antibiotics i.e. antibiotics that 
leave the anaerobic flora thought to be responsible for colonization resistance 
undisturbed (Table 3.4). However, there are indications that even when indifferent 
antibiotics are used, some impairment of colonization resistance can occur-27 . 
Table 3.3 Factors adversely affecting colonization resistance 
Irradiation 
Chemotherapy, immunosuppressive agents 
Stasis of food and mucus, bacterial overgrowth 
Intubation and mechanical ventilation 
Aspiration, regurgitation 
Bower dysfunction or retention 
3.4 Prevention of colonization by antibiotic prophylaxis 
Efforts to prevent colonization using inadequate antibiotic regimens are disappoin-
ting28 and result in cofonization with resistant strains29-30 causing persistent 
infections with htgh mortality rates. These infections, occurring during antibiotic 
therapy and caused by PPM resistant to the antibiotics used, are known as 
superinfections. As early as 1947 Weinstein 31 had ascribed superinfections with 
resistant gram-negative PPM to the disturbance of the microbial equilibrium 
resulting from the use of antibiotics, and in 1970 Price and Sleigh32 were able to 
end an epidemic of infections with multiresistant Klebsiella aerogenes by the 
withdrawal of ampicillin and cloxacilline, drugs in use in their ICU for a period of 
2 years. They thought the previously sensitive microbial flora was quickly replaced 
by nosocomial gram-negative bacilli resistant to the antibiotics in use, resulting in 
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superinfections. By discontinuing all antibiotics the normal flora could be restored 
and colonization again be prevented by the restoration of colonization resistance. 
Attempts to eradicate PPM by total decontamination of the gut and skin in 
combination with complete isolation seemed worthwhile in granulocytopenic pa-
tients, but needed strict patient compliance, were expensive, and only 30 to 40% 
of all cases proved successfui3s-35 • Again the danger of acquisition, colonization and 
overgrowth of resistant micro-organisms was increased in the unsuccessful cases. 
The concept of colonization resistance made it possible to introduce a novel 
method of infection prevention, named selective decontamination by van der 
Waays.z,_ 
Table 3.4 Antibiotics indifferent to colonization resistance 
Oral: Polymyxin E 
Doxycycline 
Tobramycin 
Ouinolones 
Co-trimoxazole 
Trimethoprim 
3.5 Selective decontamination 
Intravenous: Cefotaxime 
Ceftazidime 
Cefuroxime 
Aminoglycosides 
Quinolones 
Co-trimoxazole 
Trimethoprim 
Selective decontamination has been in use since the early 1980's in patients with 
granulocytopenia, with promising results36·37 • Subsequently, its use in patients in 
the ICU has become the subject of interest. Stoutenbeek et al.38 were the first to 
study selective decontamination using a modified regimen in patients with trauma 
in the ICU and who had been intubated for more than 5 days. They used a 
combination of non-absorbable antibiotics to reach high topical levels in the 
oropharynx [pastel and gut [suspension), thus minimising the risk of resistance. 
Nevertheless, a considerable number of infections still occurred, mainly because 
the patients suffered from primary respiratory tract infections, caused by 
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community-acquired micro-organisms which occurred within 48 hours of 
admission. With the addition of systemic cefotaxime in the first days the rate of 
respiratory tract infections declined from 59 to 8% and the overall infection rate 
dropped from 81 to 16%39 • The use of cefotaxime can be discontinued when 
adequate decontamination has occurred, as indicated by surveillance cultures (no 
PPM grown); this systemic antibiotic serves as a protection against early (primary) 
infections during the first days when selective decontamination has not yet been 
fully established. Others have changed antibiotic components in the originally 
described regimen 38 (Table 3.5), with similar effects on the reduction of infection 
(Table 3.6). Most studies aimed at lowering the number of pulmonary tract 
infections but some additionally reported a significant decrease in the number of 
abdominal abscesses41 , urinary tract infections38·42•47, septicemia~18·41 "42• 50 and 
wound infections38·45 . There are however several studies which could not detect 
a beneficial effect of selective decontamination on infection rates (Table 3.6), these 
studies predominantly evaluated medical patients and offer fertile ground for 
discussion. 
3.6 Practical use of selective decontamination 
There is much debate concerning the use of stress ulcer prophy.laxis (sucralfate or 
H2-blockers) causing bacterial overgrowth and enhancing retrograde (endogenous) 
colonization of the oropharynx ( chapter 2, pp 27 I. Since both selective 
decontamination and H2-blockers or antacid a influences colonization, controversy 
exists about the efficacy of either regimen in preventing colonization and 
pulmonary tract infection. Until now, two studies compared the use of selective 
decontamination and H2-blockers with either sucralfate alone62 or sucralfate with 
selective decontamination in contrast to H2-blockers in a third group51 . The former 
resulted in less infected patients in the group with selective decontamination and 
H2-blockers (12 vs. 27%,p = 0.041 compared with sucralfate but showed no 
effect on mortality. The latter study showed less pulmonary tract infections in the 
group with selective decontamination and H2-blockers compared to H2-blockers 
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Table 3.5 Selective decontamination regimens38.4°·62 
Enteral !mgl 
Regimen Reference I 
EnteraL Oropharvngeal and Systemic Antibiotics3 : 
PTAC 38,40,44, 
PNAC 
PNATr 
PNBTA 
47,54,61° 
48,55° 
57 
41b 
45° 
43 
42 
51° 
100 
100 
100 
200 
200 
200 
200 
Enteral and oropharyngeal antibiotics: 
80 
80 
80 
80 
80 
80 
PTA 60 100 80 
Only oropharvngeal antibiotics: 
PTA 49 
Only enteral antibiotics: 
PTA 461,50 100 80 
f § 
PGA 529 50 80 
PNeV 53' lx 61 35 
PGNy 56.62 100 80 
PNeNa ss' 50 
NNy 58 
50 
50 
Ne 
250 
1000 
500 
500 
500 
500 
500 
500 
500 
500 
100 
500 
!:!. 6. 
(300) 
5QQ X 3 
P= Polymyxin E, T= Tobramycin, G= Gentamycin, A= Amphotericin 8, 
N= Norfloxacin, C= Cefotaxime, Tr= Trimethoprim, Ne= Neomycin, 
Na = Nalidixic acid, Ny = Nystatin, v = Vancomycin 
Systemic (mgl 
500 
1000 X 3 
1000 X 6 
500 
500 
500 X 3 
? 
No 
500 
No information 
':!. Na !:!.Y 
250 
106 X 2 
1000 
1Q.QQQ X 4 
a. All regimens except 53 given four times a day, and except for study 45 starting on admission-day; 
systemic prophylaxis was given for 4 days, except for study 41 and 61. All studies except 46 and 
59 achieved oropharyngeal decontamination by a 2% mixture of the enteral antibiotics in orabase. 
b. Cefotaxime in both groups for 72 hours {study 61) or for 5-7 days (study 41 ). 
c. Systemic antibiotics were cefotaxime and ampicillin (4 x 1 000) or ciprofloxacin {2 x 200), control 
patients received nystatin 4 times daily. 
d. Regimen starting 3 days prior to operation. 
e. Oropharyngeal decontamination by a spray containing polymyxin B, neomycine and bacitracin. 
f. 2% povidone-iodine lozenge instead of oropharyngeal paste. Amphotericin 8 in study as well as 
control groups in study 46. 
g. Amphotericin B only oropharyngeal. 
i. Oral lozenge, after 1 minute swallowed. 
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Table 3.6 Selective decontamination trials and results: all infections and the subgroup 
of pneumonia38·40·62 
lnfe£!ion rate {~! Mortali!:t rat~ {0&!1 
Control Study Control Study 
Ref ~ !of:. lW!I!I! lW!I!I! .9!.Qill?. .Q!.Q1!.Q. Subgroup 
38 H All 81 16 not mentioned 
Pn 59 8 
40 H All 24 10 24 24 
3 0 Polytrauma 
41 R All 81 39 32 28 
17 4 !nf.related 
42 R All 77 52 54 31 
15 0 Septicemia 
Pn 44 6 
43 R Pn 62 6 10 12 
44 H Pn 42 6 not mentioned 
45 R All 55 21 3 5 
Pn 14 2 
46 DPI Pn 8 0 18 12 
20 4 ~ 7 days 
47 DPI Pn 45 10 47 38 
74 36 ? Cardiac Surgery 
48 H All 83 33 42 40 
Pn 42 7 
49 DPI Pn 73 0 30 33 
50 R Pn 43 2 92 62 
80 69 ? Abdom.Surgery 
81 50 ? Polytrauma 
51 H Pn 47 10 52 24 • 
52 R Pn 45 5 30 26 
53 DPI Pn 78 16 26 28 
54 R All 31 17 • 19 15 
21 11 Apache 10·19 
Pn 82 48 
55 R All 50 14 ? 
56 R All 25 13 21 15 
57 DPI All 63 26 44 21 
Pn 46 15 20 2 lnf.related 
58 DPI All 71 48 48 52 
59 R All 34 33 not mentioned 
61 RD Pn 4 2 38 34 
62' DPI All 34 26 17 18 
All 46 24 Apache 17-23 
Ref= References,Des= Design; Historical {H) or Randomised {R) controls, Double-blind (D), Placebo controlled (PI). 
!nf. = Infections; All or Pneumonia (Pn), Abdom. = Abdomina!. 
a : Only mid-range APACHE II had significantly lower infection rates 
: p < .05 
: p < .001 
? : p not mentioned. 
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alone (14 vs. 49%, p < 0.05), mortality was not significantly lower (35 vs. 54%). 
The use of sucralfate with selective decontamination resulted in a further decrease 
of pulmonary tract infections (7%) but additionally in a significant decrease in 
mortality in contrast to H2-blockers (18 vs. 54%, p < 0.01 ). 
Patients with cystic fibrosis does not seem to benefit from selective 
decontamination63 , but the regimen in this study consisted of oropharyngeal 
application of an antibiotic gel in combination with long-term systemic antibiotics. 
The possibility of eradicating an epidemic of infection with multiresistant PPM's 
has been raised59·64, but with the use of only enteral drug administration no effect 
on infection rates could be demonstrated in one of these studies59 • The effect of 
selective decontamination on mortality is also subject of discussion; either no 
effect has so far been demonstrated, or the only positive effect is found in 
subgroups such as patients with trauma40 or following cardiothoracic surgerf7 , or 
in those with long-term ICU admission46 (Table 3.6). Only few randomised studies 
showed a significant decrease in the overall mortality, but in one study a very high 
mortality rate in the control group was reported 50 • Kerver et al. 41 have shown an 
effect on infection-related mortality, but the results of Ulrich et al.42 in this regard 
have been disputed because they 'treated' colonized patients in the test-group 
before infections could arise. As described earlier, overall mortality in a study using 
historical controls was decreased, but results were obscured by the use of stress 
ulcer prophylaxis''. 
Adverse effects have been described, but are until now of minor relevance. 
Many clinicians have observed the (expected) shift from Gram-negative to Gram-
positive micro-organisms (S.epidermidis, S.aureus, Enterococct) as causes of 
infection, but these infections are not difficult to treatss,4o,45·65 . McClelland et a1.66 
described failure of recognition of a perforation peritonitis due to S.epidermidis in 
a patient receiving selective decontamination, the latter preventing culture of 
"typical" Gram-negative organisms. 
The possible emergence of resistance will remain to be a cause for attention 
and justifies the use of surveillance cultures. However, no increase in resistance 
has been reported so far, presumably because the combination of antibiotics in 
high enteric dosages makes resistance improbable. The non-absorbable antibiotics 
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suitable for selective decontamination do not reach tissue levels adequate to treat 
deep organ infection and are therefore not in general use; this minimises the danger 
of developing resistance67 • 
!n choosing antibiotics for their use in selective decontamination, faecal 
adsorption as described for polymyxin68 and the quinolones69 has to be considered 
because this influences free drug concentration on the colonic mucosa and 
therefore the microbiologicar part of colonization resistance. The parenteral 
administration of metronidazole, in genera[ use in gastro-intestinal surgery for 
prophylaxis of wound infection, is in this regard permitted because the intraluminal 
drug concentration is too low to affect colonization resistance70 . 
The use of selective decontamination has shown to be an effective method 
of retaining or enhancing colonization resistance in critically ill patients and has ted 
to a reduction of the offensive load of gram-negative nosocomial PPM, thereby 
reducing life-threatening infections in most studies. 
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4.1 Introduction 
Hospital-acquired infections cause substantial morbidity and mortality, especially 
on surgical wards and intensive care units (ICU) 1"10 • Most of these infections are 
endogenous, since they are preceded by colonization of the gastrointestinal tract 
and oropharynx by increasingly multiresistant gram-negative bacilli (GNB) 2•5•11 "14• 
Setective decontamination (SD) is a procedure to eliminate these organisms from 
the digestive tract leaving the anaerobic flora unaffected. The anaerobes are part 
of the first-line of defence in the gut (colonization resistance 15), and they play an 
important part in the prevention of overgrowth of GNB16• Results of earlier trials (in 
which non-absorbed antibiotics were used) in granulocytopenic patients were 
promising and use of selective decontamination in these patients has been 
accepted 17•16• However, the benefit of modified regimens of selective decontamina-
tion in intensive care patients remains controversial. A reduction in infection-rate 
from 81 % to 16 % was reported by Stoutenbeek et al 19 who used selective 
decontamination with systemic cefotaxime in 122 multip!e trauma patients with 
a moderately long ICU-stay (;;,: 5 days). ledingham et al20 advocate the use of this 
antibiotic regimen for unselected groups of patients in non-specialised ICU's; they 
found a 24 to 10% reduction in acquired infections in patients on a general I CU. 
A criticism of previous trials is that historical controls and heterogeneous patient-
populations were studied•. 
We report a prospective, randomized study on the effects of selective 
decontamination in a homogeneous group of patients undergoing elective 
oesophageal resection for carcinoma; we chose this group because there is a high 
frequency of lower respiratory tract infections with GNB due to lower colonization 
resistance in such patients. 
4.2 Patients and methods 
Previous infection rate 
To estimate the infection rate for oesophageal resection in our hospital before the 
trial, we assessed data from 75 patients (54 men, 21 women; mean age 59,5 
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years, range 39-78) who had had surgery for oesophageal carcinoma in 1985; they 
had been examined by endoscopy, computed tomography, and ultrasonography. 
Only patients who had no local ingrowth and no distant metastatic disease were 
judged to be operable. Since 1983, cefamandole and metronidazole (4 times 1 g 
respectively 3 times 500 mg a day, 24 hours perioperatively, that is :,; 1 h before 
until about 24 h after surgery) were used as prophylaxis in this type of operation. 
Mean length of time in hospital and ICU was 34 days (range 21-1 05) and 6,5 days 
(1-48), respectively. Pneumonia developed in 16 patients (21 %), urinary tract 
infection in 4 (5%). and septicemia in 5 (7%); 5 patients {7%) died. The infection 
rate and mortality for the 5 years before the study were similar to those for 1985 
(20% and 5%, respectively). 
Patients and controls 
Between March 1986 and December 1988, 181 patients who were going to have 
surgery for oesophageal carcinoma were included in the study. On admission to 
hospital the patients were randomised {fixed block size, n = 8) and allocated either 
to a control group {standard antibiotic prophylaxis) or to a test group {SO-
medication combined with systemic cefotaxime during the first 4 days). For all 
patients the bowel was cleared {laxatives and enemas) during the 3 days before 
surgery. Until November 1986 a combined right-sided thoracotomy and median 
upper laparotomy was done on the 4th day. Thereafter the operative technique 
was changed to mobilising the oesophagus and tumour by blunt dissection through 
a laparotomy, and using a second incision in the neck to complete the oesophagec-
tomy. The upper digestive tract was reconstructed with a tube made from the 
remaining stomach, or by colonic interposition in 4 patients in each group (Table 
4.1 ). The actual oesophageal resection was an important inclusion-criterium for 
analysis. 
67 patients were excluded from the trial because oesophageal resection was 
not done (tumour not resectable in 42 patients, tumour of cardia not involving the 
oesophagus in 12); SO-medication was discontinued (non-compliance because of 
taste in 2, vomiting and nausea in 4, allergy in 1 ); or other antibiotics had been 
used preoperatively (6 patients). Thus, 114 patients {56 test group, 58 control 
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group) were studied. The trial was approved by the hospital ethical committee and 
written informed consent was given by the patients. 
Table 4.1 Patient-characteristics 
Test jn-56! Control (n- 58} 
Sex IM/FI 35/21 42/16 
Age {mean) 40-77 1601 42-78 160.61 
Cardiac history 4 10 
Pulmonary disease 8 7 
Preoperative irradiation 30 33 
Surgical technique {n"l 
Thoracotomy 18 132%1 18 131%1 
Stomach-tube 50 51 
Colonic interposition 4 4 
Jejunal interposition 2 3 
No of retnterventions 7 112%1 7 112%1 
Admission (n° of days) 
ICU-stay/patient (mean) 1-99 15.51 0-35 14.91 
!CU-stay/group 310 286 
Hospital-stay/patient 14-103 125.61 11-91 127.71 
Hospital-stay/group 1434 1608 
Mortality 3 2 
Specific medication 
SO-medication consisted of a sticky ointment (OrabaseR, Squibb), containing a 
mixture of 2% polymyxin E, 2% tobramycin and 2% amphotericin B, applied four 
times a day on buccal mucosa; a suspension of the same drugs (200, 80, 500 
mg,respectively) was given at 6 h intervals by mouth, nasogastric tube, or needle 
jejunostomy. This regimen was started on the day of admission, and continued 
until the 1 O'' postoperative day (or longer if infection had not resolved); specific 
antibiotics were also given. We chose this 1 0-day period because the high risk for 
aspiration and other respiratory disorders in these patients lessens quickly after 10 
days, as we had previously experienced. Systemic cefotaxime (1 g, four times a 
day) was added as supplementary prophylaxis for the first 3 days before surgery, 
during which selective decontamination is not yet fully established, and was 
discontinued after surgery (day 0). On the day of operation, systemic metronida-
zole (500 mg, 3 times a day) is added as part of the usual (24 hour) prophylaxis 
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in bowel surgery. Antibiotic prophylaxis in the control-group consisted of systemic 
cefamandole and metronidazole (4 times 1 g respectively 3 times 500 mg a day). 
for 24 hours peri-operatively, as is generally accepted for routine bowel surgery 
and in use since 1983. It was therefore continued in control patients for better 
comparability. 
Bacteriology 
Cultures from nose, throat, sputum (when present). urine and faeces (or rectal 
swab) were taken on admission, and thereafter three times a week. Drains, gastric 
contents and feeding fistulae were also cultured. Identification of pathogenic micro-
organisms and antibiotic sensitivity tests were done according to internationally 
accepted laboratory practice. Definitions are given in chapter 2, pp 35. 
Follow-up 
All patients were examined daily for clinical signs of infection during their 
admission; diagnosis of infection was confirmed by culture. Chest radiographs 
were taken daily during the first 3 postoperative days and thereafter if clinically 
indicated. Radiographs were judged by the same radiologist and chest-physician 
each time, both of whom were unaware of the group the patients had been 
allocated to. When a lower respiratory tract infection was suspected cultures from 
lobular aspirations were taken by bronchoscopy.ln both groups treatment was only 
started when there was clinical and microbiological evidence of an infection, 
although antibiotics were sometimes empirically started when needed. Antibiotics 
were chosen according to hospital guidelines based on the sensitivity patterns of 
the isolated micro-organisms. In the test patients, antibiotics that would not affect 
colonization resistance were given. None of the patients was given H2-blockers. 
Statistical analysis 
To detect a significant reduction in postoperative infections, 56 patients were 
needed in each group, with a and ~ at 0,05 (based on the infection rate for 
oesophageal resection before the study). The chi-square test (with Yates-
correction) and two-sided Fisher's exact test were used to compare frequencies. 
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To compare the number of infections and non-infectious complications, we used 
the Mann-Whitney test. A p value of 0,05 or less was regarded as significant. 
4.3 Results 
Table 4.1 shows that the two groups were broadly similar. To exclude any 
influence of the change in surgical technique on infection rates, we analyzed all 
infections in patients who had had a thoracotomy (n = 36) and in those who had 
not had one (n=78). Infections developed in 13 (36%) and 33 (42%) patients; 
lower respiratory tract infections in 5 and 8 patients, respectively. These 
differences were not significant. 
Table 4.2 Acquired infections in the first 10 postoperative days 
Test Qatients {n- 56} Control gatients {n- §8) 
!nfe~ion ~ GramM Total Gram+ Gram- Mixed Total 
Pulmonary 1 0 1 12%1 2 4 2 8 114%1. 
Urinary tract 3 2 @ 519%1 4 7 2 13 122%1 
Wound 6 0 6 111%1 9 5 6 20 135%1 + 
Septicemia 1 0 1 12%1 1 0 0 1 12%1 
Other §. Q 519%1 ;> 2. ~ _g ~ 
Total 16 2 18 19 18 14 51 
% 89 11 # 37 35 # 27 
• <0.05, + <0.01, #<0.001 for controls vs.test patients. 
@ = not preceded by colonization; 4 causative organisms. 
Infection rates 
During the first 10 postoperative days, 32 controls had 51 infections whereas 12 
test patients acquired 18 infections (p < 0,001 ); there were significantly fewer 
respiratory tract infections and minor wound infections in the test patients (Table 
4.2). All infections were secondary, except for 2 urinary tract infections on 
admission, which were not included in this analysis. Most infections were 
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endogenous (test group 83%, controls 73%). In the control group 54% (46/85) of 
the causative microorganisms were GNB (Pseudomonas sp, Proteus sp, Klebsiella 
sp, Enterobactersp, Acinetobactersp, Citrobactersp, and Escherichia coftl, 41% 
(35/85) were gram-positive cocci (Staphylococcus epidermidis, S.aureus and 
Enterococcus sp) and 5% (4/85) were gram-negative diplococci (Neisseria sp and 
Branhamel!a sp). By contrast, in test patients GNB !Pseudomonassp, Acinetobacter 
sp, and E coli) accounted for 15% (4/27) of infections and gram-positive cocci for 
85% (p< 0,001, Table 4.3). 12 new infections arose in 4test patients after SO-
medication had been stopped at 10 days: 3 were respiratory tract infections (Table 
4.4). 2 patients had not had a previous infection, but were heavily colonised with 
GNB after discontinuation of SO-medication. Half the infections were gram-
negative or mixed (Table 4.3). In contrast, 1 pulmonary tract infection, caused by 
GNB developed in a control patient. 
Table 4.3 Micro·organisms causing infections 
First 1 0 d3!£S After 1 0 da~s 
SD Control SD ec. mol 
~ram-negative SQecig§; *: 
Pseudomonas 1 11 4 
Acinetobacter 2 7 
Escherichia Coli 11 
Proteus 6 3 
Klebsiella 7 
Enterobacter 3 2 
Citrobacter 1 
Neisseria 3 
Branham ella 1 
Gram-Qositive sgecies: 
S.epidermidis 14 17 7 
S.aureus 1 3 5 
Enterococcus 8 15 2 
S. = Staphylococcus 
Number of gram-negative micro-organisms, infections in the first 1 0 
postoperative days: p<0.001, Fisher's exact test. 
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In a small subgroup of patients (n = 26), who stayed for more than 4 days 
on the ICU, the reduction in infectious complications and the number of respiratory 
tract infections seen using selective decontamination, is not significant. 5 controls 
got respiratory tract infections compared with 1 test patient. The therapeutic use 
of antibiotics in the postoperative period was significantly different in the two 
groups; 25 controls and 11 test patients needed specific antibiotics (p = 0,013, 
Chi-square test). 3 test patients died (5%); in 2, infections were contributory 
factors. In the control group 2 patients (3%) died of non-infectious causes. 
4.4 Discussion 
Table 4.4 Acquired infections after 10 days 
Put mcnary tract • 
Urinary tract 
Wound 
Other 
Total# 
•: p=0.487, Fisher's exact test. 
#: p = 0.171, Mann-Whitney test. 
3 
1 
3 
5 
+ 
12 
We have shown that selective decontamination reduces postoperative infections 
caused by GNB after elective oesophageal resection and one-stage reconstruction. 
Factors that may have influenced infection rates, such as a thoracotomy or colon 
interposition were equally distributed among both groups; moreover, there were no 
significant differences in postoperative infectious complications fort he two surgical 
procedures. 
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Between 1983 and the beginning of the present study the systemic 
prophylaxis, indicated in this kind of operation21 was cefamandole and metronida-
zole, 24 hours perioperatively. We decided to give the same systemic prophylaxis 
to the control group to detect any influences on infection rates, even though a 
different medication strategy was given to test patients- namely, cefotaxime and 
metronidazole. We did not expect the results to be influenced by this difference 
because cefotaxime was only used pre-operatively and during the day of operation, 
and cefamandole was given to control patients also for 24 h perioperatively. 
Mandelli and colleagues22 did not find an effect of systemic prophylaxis on the 
occurrence of early onset pneumonia in patients in the I CU. Moreover, since the 
half-life of cefotaxime does not exceed 1 hour23, we believe that the influence of 
this drug on the outcome was negligible. For better comparability, metronidazole 
was given systematically to both groups: the anaerobic gut flora is not affected 
because intraluminal concentrations are too low24 . 
We did not do a double-blind study, because knowledge of culture results 
is essential to the physicians in charge of the patients, as surveillance cultures are 
an essential part of selective decontamination. The number of gram-positive 
infections in the test group was striking, and indicates how important such 
surveillance cultures are, since gram-positive organisms are not eliminated by this 
prophylaxis. Cultures are also necessary to detect the development of resistance 
during the use of antibiotics. The reason why the number of urinary tract infections 
was non-significantly reduced with SD prophylaxis was probably because most 
nosocomial urinary tract infections are associated with instrumentation25 and all of 
our patients had indwelling urinary catheters. 
That patients were rapidly colonised by GNB after discontinuation of SD 
medication points to a protective influence of selective decontamination, and 
suggests that SD prophylaxis in these patients should be continued. We cannot 
comment about a possible effect of selective decontamination on mortality because 
of the low mortality rate in this group of patients. 
Although the reduction in infection rate led to a significant reduction in the 
number of patients needing therapeutical systemic antibiotics in the test group, this 
reduction did not influence the length of admission as noted by others5•9 • In this 
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group of patients however, the hospital stay depends in our view on surgical 
complications, which were equally distributed in both groups. Although we could 
not show a beneficial influence of selective decontamination in patients staying for 
more than 4 days in the ICU, there was a substantial reduction in the number of 
respiratory tract infections in this small group who are highly susceptible to gram-
negative bacterial infections2-4·6·8•19 . With more patients to study, a possible 
beneficial effect would probably also been found in this group with long stay. 
This study was financially supported by Eli Lilly and Roussel BV, the Netherlands. 
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5.1 Introduction 
One third of all patients on an intensive care unit {ICU) experience complications 
resulting in an estimated mortality of 40 %'. Among these complications, 
nosocomial infections are life-threatening, increasing the infection-related mortality 
to as much as 50%'"'. The incidence of nosocomial infections on the ICU is 5 to 
10 times as high in comparison to the ward 1 • In addition, 25% of the nosocomial 
infections emerge in ICU-admitted patients, including 41% of all hospital 
septicemia's and respiratory tract infections2·6 • After 2 weeks, 80% of these 
patients have infections'·11 , of which more than 60% are caused by gram-negative 
micro-organisms 12 • 
A relatively constant event, preceding infections in hospital-admitted patients 
is the colonization of the oropharynx and gastro-intestinal tract with gram-negative 
bacilli (GNB)"·"- Especially oropharyngeal colonization with GNB is strongly 
associated with the subsequent development of respiratory tract infections, while 
more than 75% is preceded by oropharyngeal colonization with the same micro-
organism4'11'13'20. Wound-, and urinary tract infections are related to preceding 
gastro-intestinal colonization18 '21 and the presence of indwelling catheters or 
instrumentation21 • More than 50% of all !CU-admitted patients is already colonized 
with the pathogen that subsequently causes their nosocomial infection22, so 
measures to reduce or prevent infections in these patients must include ways to 
reduce the acquisition and colonization of GNB. 
Selective decontamination (SDI aims to eradicate these GNB from the 
oropharynx and digestive tract while leaving the anaerobic flora undisturbed. 
Selective decontamination maintains the colonization resistance (CR) thereby 
preventing the colonization with GNB and reducing the number of gram-negative 
infectionS23.26 • 
A prospective, randomised study to the effects of selective decontamination 
was conducted in a homogeneous group of patients with oesophageal carcinoma, 
admitted to have a one-stage resection and reconstruction of the alimentary tract. 
These patients develop postoperative pulmonary tract infections mostly caused by 
gram-negative micro-organisms with a frequency of 20%, due to the disturbed 
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colonization resistance. Clinical results on infection rates were presented in chapter 
4, in this chapter we describe the effects on gram-negative microbial colonization. 
Since each new antimicrobial regimen can promote the overgrowth or 
acquisition of resistant strains by producing profound changes in the intestinal 
microf!ora1·2e-27, surveillance of bacterial resistance will be continuously needed. One 
third of all gram-negative micro-organisms resistant to aminoglycosides are isolated 
on the iCU', and most resistant strains in hospitals are thought to originate from 
colonized or infected patients, acting as a reservoir". Therefore we additionally 
evaluated the effects of selective decontamination on the development of bacterial 
resistance. 
5.2 Patients and methods 
Patients 
On admission, patients analyzed and found eligible for oesophageal resection were 
randomised by means of fixed block size (n = 81 randomisation and allocated to a 
control-group receiving the standard antibiotic prophylaxis used since 1983 in this 
kind of operation, or a test-group receiving SO-medication with systemic cefota-
xime during the first 4 days. During the first 3 pre-operative days of admission, a 
mechanical bowel-preparation was achieved in all patients and selective decontami-
nation was established in test-group patients, after written informed consent was 
obtained. Operation takes place on the fourth day, after which all patients were 
transferred to the surgical intensive care unit and mechanically ventilated. This 
study was approved by the hospital ethical comminee. 
Specific medication 
Patients in the test-group received SO-medication, as described in chapter 4 (pp 
65), consisting of polymyxin E, tobramycin and amphotericin B. A 2% mixture of 
these drugs in orabaseR was applied four times daily on the buccal mucosa, and a 
suspension of the same drugs, (respective doses 200, 80 and 500 mgl was given 
in the digestive tract at 6 h intervals (Table 5.1 ). 
Table 5.1 Medication 
SD~medication ltest-groupl: 
Polymyxin E 
Tobramycin 
Amphotericin 8 
Systemic prophylaxis 
test group 
control group 
SO: Selective decontamination 
Oropharvnx1 
2% 
2% in orabase 
2% 
: Cefotaxime2 
Metronidazole3 
: Cefamandole3 
Metronidazole3 
Digestive tract 1 
200 mg. 
80 mg. suspension 
500 mg. 
4 X 1 g. 
4 x 500 mg. 
4 X 1 g. 
4 x 500 mg. 
1. Starting on admission-day, every 6 hours, until 10 days post-operatively. In case of an 
infection, continued until clinically stable and mob.llised. 
2. Starting on admission--day, discontinued after the operation. 
3. Only 24 hours, on the day of operation. 
Bacteriology 
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Bacteriological cultures from nose, throat, sputum, urine and faeces (or rectal 
swab) were taken at admission and thereafter three times weekly. On indication 
cultures from wounds, drains and feeding fistulae were taken. Identification of 
pathogenic micro-organisms and testing on antibiotic sensitivity was done 
according to internationally accepted laboratory practice. Definitions are given in 
chapter 2, pp 35. 
Epidemiology and Resistance 
All strains resistant to the antibiotics used were recorded in both groups. Also, 
weekly rectal swabs were taken from patients on 4 fixed beds on the surgical ward 
and I CU. Isolated micro-organisms were tested on their sensitivity to aminoglycosi-
des, and third generation cephalosporins. These data were compared with data 
from years preceding this study, also considering the antibiotic usage on the ICU 
and ward. 
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Statistical analysis 
To detect a significant reduction in postoperative infections, 56 patients were 
needed in each group, when fixing a and 1?, on 0,05 and considering the 20% 
infection-rate in the years preceding this study. To compare frequencies we used 
the Chi-square test {with Yates-correction) and two-sided Fisher's exact test. To 
compare the number of infections and non-infectious complications, we used the 
Mann-Whitney test. A p-value of 0.05 or less was considered significant. 
5.3 Results 
From march 1986 until december 1988 there were 181 patients eligible for the 
study, but 67 patients were excluded from further evaluation as has been 
described in chapter 4. Despite thorough analysis 42 patients proved to have 
metastasis at laparotomy so no oesophageal resection was performed, 12 patients 
had no oesophageal resection because the tumour of the cardia did not extend into 
the oesophagus, and another 13 patients showed adverse effects or used other 
antibiotics pre-operative. From the remaining 114 patients, 56 received SO-
medication and 58 patients got the conventional antibiotic prophylaxis. Both 
groups were highly comparable regarding the most important parameters. 
Colonization 
On admission, baseline-cultures revealed that 68 patients {60%) were carrier of 
gram-negative micro-organisms in the oropharynx {mostly Neisseria sp) and 88 
{77%) carried GNB {predominantly Escherichia colt] in the gastro-intestinal tract. 
When disregarding E.coli, 21 patients (18%) carried GNB in the digestive tract 
{Table 5.2). Gram-positive micro-organisms (Difteroids, Streptococci, 
Staphylococcus epidermidis) were present in the oropharynx in 94 patients (82%1 
and in 84% of the patients in the gut (Table 5.3). 
At operation-day, 93% of SO-medicated patients were free of gram-negative 
micro-organisms in the oropharynx, with none of the patients having gram-negative 
bacilli in the respiratory tract. Furthermore, 95% ofthe patients were free of GNB 
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Table 5.2 Colonization with gram-negative micro-organisms 
Admission Dav 0 Da!£ 1-10 • After 1 0 da~s 
orogha!:inX 
SD 26 (46%) 4 (7%) 2 {4%) 10 (18%) 
Control 42 (73%) 27 (46%1 24 (42%) 
Re§;giratQD£ tract 
SD 7 (13%) 6 (11%) 
Control 11 (19%) 11 (19%1 33 (54%) 
Alimen12D:: tr!!~ 
SD 43 177%) 3 ( 5%) 19 (34%) 
Control 45 (77%) 21 (36%1 2o 135%1 
Urinaa! tract 
SD 11 (20%) 5 (9%) 2 (4%) 
Control 7 (12%) 13 (22%1 34 (58%) 
SD: Selective decontamination 
p < 1()"6, Chi-square test 
in the rectum, and none showed GNB in the urinary tract (Table 5.21. During the 
first 10 postoperative days gram-negative colonization could be prevented in all but 
7 patients receiving SO-medication while most control-patients were colonised with 
new GNB (p < 1 o·•, Chi-squaretestl. With discontinuation of selective decontamina-
tion after 10 postoperative days colonization with GNB occurred within 3 to 4 days 
in 10 patients {18%1 in the oropharynx and in 19 patients {34%1 in the alimentary 
tract. 6 patients (11 %1 showed colonization with gram-negative bacilli in the 
respiratory tract, 4 (7%1 in the urinary tract (Table 5.21. With respect to the gram-
positive bacilli, up to 52% of SO-medicated patients and 85% of the control 
patients showed colonization with these micro-organisms during this period (Table 
5.31. 
Bacterial resistance 
One (1 ,8%1 SO-medicated patient was colonised during the study with a resistant 
Acinetobacter. Two (3,3%1 control patients were colonised with Pseudomonas 
strains. Epidemiological data on resistant aerobic gram-negative bacilli are 
summarized in Table 5.4: as can be seen no significant differences were found, in 
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spite ofthe increased amounts of aminoglycosides and cephalosporins used on the 
ward and ICU (Table 5.5). 
Table 5.3 Colonization with gram-positive micro-organisms 
Admission ~ Da~1-1Q After 1 0 da~s 
QrQQhaD!nX 
SO 45 (80%) 4 ( 7%) 29 (52%) 13 (23%) 
Control 49 185%) 38 (65%) 9 (15%) 
Bgs:gira!OCI! 1ract 
so 17 (30%) 5 ( 9%) 21 (37%) 8114%1 
Control 20 135%1 18131%1 18131%1 
Aliment§D::: trS!~ 
so 51 191%1 316%1 22 140%) 9 (16%) 
Control 45 177%) 22 (44%) 29 150%) 
1lrina!Jl tra~t 
SO 13 133%) 1 12%) 29 152%) 19 (34%1 
Control 24 (42%) 214%) 46 (85%) 
SO: Selective decontamination 
5.4 Discussion 
Patients undergoing one-stage oesophageal resection and reconstruction are 
susceptible to get respiratory tract infections. Already pre-operative the coloniza-
tion-resistance is diminished because of the primary disease, mucosal damage 
following irradiation and disturbed physiological cleaning mechanisms. Post-
operative coughing and sighing is impaired because of the pain originating in the 
thoracic and upper abdominal wounds, in addition to the altered peristalsis and 
regurgitation. 
Selective decontamination is established in most of these patients within 3 
to 4 days, in contrary to the longer periods 17-12 days) in other studies•. This is 
probably due to the functional gut in the pre-operative days during which a bowel 
preparation is performed and selective decontamination is established. Furthermore 
colonization with GNB could be prevented in almost all SO-medicated patients, 
Table 5.4 Resistant (Rf aerobic gram-negative bacilli. 
epidemiological study 
Before SO 11985! After SD (19871 
Deoartment ~mQied! R §am:gl~~ f R ~h'i-sguar!i 
ICU 88/12(13.6%1 83/15(18.1%1 n.s. 
AG: 6 AG: 10 
3C: 6 3C: 5 
Ward 77/ 3(3.9%1 162 I 3(1.8%1 n.s. 
AG: 3 AG: 2 
3C: 0 3C: 1 
SD: Selective decontamination 
Resistant to one or more aminogrycosides (AGJ and I or third generation 
cephalosporins (3CJ. 
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except for 2 patients having oropharyngeal colonization without colonization of the 
respiratory tract and 5 patients showing colonization in the urinary tract, probably 
as a result of indwelling catheters (Table 5.2). 
The rebound colonization after discontinuation of SO-medication resulted in 
3 gram-negative pulmonary tract infections in 2 patients (chapter 4, pp 68). This 
illustrates the importance of gram-negative oropharyngeal colonization in the 
pathogenesis of these infections, because these 2 patients were heavily colonized 
with the causative micro-organisms before the infections occurred. On the other 
hand, 10 patients (18%1 showed oropharyngeal and 6 (11 %) showed respiratory 
tract colonization with gram-negative bacilli in this period, indicating a more 
complex relationship between colonization, host-factors and infections. The 4 
patients having late infections all suffered from surgical complications such as 
suture leakage which necessitated reinterventions and longer admissions on the 
ICU, and perhaps these patients will benefit from longer continuation of SO-
prophylaxis. 
In this study, we saw no increase in resistant strains, despite the growing 
amounts of antibiotics used (Table 5.4 and 5.5). The possibility of resistance 
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developing under antibiotic pressure must however be recognised, and therefore 
a close surveillance remains mandatory. 
Table 5.5 Use of aminog!ycosides and third generation cephalosporins 
in surgical wards and ICU 
Gentamycin and Tobramycin 
ICU 
Ward 
Cefotaxime and Ceftazidime 
ICU 
Ward 
1985 
gram/ratio 
1986 
gramlratio 
157 
43 
271 
70 
0.06 155 
0.003 144 
0.10 587 
0.005 472 
0.07 
0.01 
0.26 
0.04 
Ratio = grams used/number of patient--days in department. 
5.5 Conclusions 
1987 
gram/ratio 
173 
143 
866 
338 
0.06 
0.01 
0.33 
0.03 
Selective decontamination of the oropharynx and digestive tract can reduce gram-
negative colonization and subsequent infections after major elective surgery. 
Selective decontamination is therefore an effective way of prophylaxis without an 
increase in resistance to the used antibiotics until now, but a careful surveillance 
is necessary to detect a possible emergence of resistance in the future. Patients 
having late complications are likely to benefit from prolonged administration of SO-
medication to prevent renewed colonization and the development of infections. 
Selective decontamination must not be discontinued until the condition of the 
patient makes pulmonary infection improbable. 
This study was financially supported by Eli lil!y and Roussel BV, the Netherlands. 
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Effects on mortality and length of admission 
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6.1 Introduction 
Several studies have shown that selective decontamination as an antimicrobial 
prophylaxis to prevent gram-negative colonization and infections in haemato-
oncological and critically ill patients on the Intensive Care Unit {ICU) leads to a 50 
to 80% reduction of infections, especially those of the lower respiratory tract1"15• 
High-risk patient-groups such as multiple trauma3 or liver-transptant patients16· 17, 
patients with mid-range APACHE-scores14, and those undergoing cardiac10•18 or 
oesophageal surgery' have been shown to possibly benefit from selective 
decontamination. 
The very high mortality-rate up to 70% in patients with a lower respiratory 
tract infection 19"23 has estab!ished a dose relation between mortafity and infections 
on the ICU. It is surprising therefore that no study has so far been able to 
demonstrate a significantly lower mortality or hospital-stay even though highly 
significant decreases of infection-rates were found using selective decontamina-
tion24·25. Possible exp!anations include that these differences are present but not 
apparent, and that patients may die with infections and not because of them. This 
would suggest that host-factors may be as important as prophylaxis"6 , The reason 
for the unclarity could also lie in the fact that until now, no study has investigated 
the relation between the efficacy of decontamination and the outcome for the 
individual patient. Instead total rates of infection and subsequent events in groups 
of patients receiving selective decontamination have been compared to those of 
controls. Most of these studies have used the APACHE II or SAP-score to match 
patient-groups in terms of "severity of illness", These scoring-systems are however 
inaccurate when heterogeneous patients from different intensive care units (ICU's) 
are studied, because diagnostic categories and the possible acute character of the 
admission are not weighed in these scores27 . Furthermore when patients are 
transferred from other hospitals or wards they introduce an underestimation of 
illness when scored by APACHE or SAP. Physiological variables, used for these 
scores, will have responded to therapy while the underlying disease is the cause 
for non-responsiveness of the patient, necessitating transferral (selection- and lead-
time bias28).Differences in diagnostic groups could then easily result in unmeasured 
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differences in mortality between patients with selective decontamination and 
control-patients. To determine the efficacy and possible benefit of new prophylac-
tic or therapeutic interventions it is therefore better to analyze only primary 
admissions and to compare actual death-rates with predicted hospital-death rates 
as described by Knaus27 • These predicted rates are calculated by a logistic 
regression formula, in which each diagnostic category, the fact whether operative 
therapy took place or not, and the possibility of emergency surgery are scored. A 
beneficial effect will result in a lower actual death rate compared to the predicted 
rate in the patient group receiving a successful new regimen, whereas groups 
without this regimen or unsuccessful use of it have an actual rate not different 
from the predicted rate. On the other hand, when predicted death rates are 
comparable between groups, they have a comparable "severity of illness" and can 
thus be compared in terms of survival and length of stay. In this report we present 
a prospective follow-up study of patients admitted to our surgical intensive care 
unit and receiving selective decontamination, with special attention for expected 
and actual death-rates. Since we expected the efficacy of decontamination to be 
of influence on infection- and mortality-rates we evaluated these rates in terms of 
successful decontamination or not. 
6.2 Patients and methods 
Patients 
Patients entered into this study were electively admitted to the ICU after a one-
stage oesophageal resection and reconstruction for carcinoma as described earlier", 
or were to have a thoraco-abdominal vascular aneurysm repair. They were given 
selective decontamination electively in combination with a mechanical bowel 
preparation starting three days prior to the operation. Furthermore, all primary 
emergency admissions with acute pancreatitis, those with complications after 
previous surgery and all trauma-patients who were expected to be ventilated for 
more than 4 days received selective decontamination and were included in this 
study. 
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Between November 1989 and May 1991, 135 patients admitted to our ICU 
received selective decontamination. After excluding 38 patients transferred from 
other hospitals, we classified the remaining 97 patients with primary admissions 
to our department according to their admission diagnosis (Table 6.1 ). Oesophageal 
resections were done by blunt transhiatal dissection via an upper median 
laparotomy, reconstruction was performed by a stomach-tube with a cervical 
anastomosis. Patients with an acute pancreatitis were operated only on demand 
to remove infected necrosis. All patients were scored according to the APACHE II 
system on admission and thereafter daily, predicted death rates were calculated on 
admission. We calculated the expected death rate for groups by adding the 
individual risks computed according to Knaus27 and dividing this by the number of 
patients. 
Medication 
Selective decontamination consisted of oropharyngeal application of Orabase" 
containing 2% of polymyxin E, amphotericin 8 and norfloxacine 4 times daily on 
the buccal mucosa and tracheostomy-sites. An enteral suspension of the same 
antimicrobial agents (200, 500, 50 mg respectively) was given by mouth, 
nasogastric tube or needle-jejunostomy also 4 times daily. With pancreatitis and 
blind enteric (mostly rectal) segments an enema containing resp. 800, 2000 and 
200 mg of the drugs was administered. This regimen was started electively 
preoperative when possible, or on admission to the ICU (acute patients) and 
continued until the patients were mobile, transferred to the ward and expected to 
have a low risk of developing pulmonary infections (estimated at 5 days after 
detubation). 
Parenteral medication was only used as direct 24 hours perioperative 
infection-prophylaxis, or during the first 5 days when selective decontamination 
was not yet fully established in patients with acute pancreatitis, and consisted of 
750 mg cefuroxime administered iv. three times daily. When infections necessitat-
ed administration of systemic antibiotics, preference was given to antibiotics 
indifferent to the colonization resistance in conformation with hospital guidelines 
and based on sensitivity patterns. 
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Table 6.1 Patient characteristics and success of decontamination 
Successful SO Unsuccessful SO 
Number of patients 72 25 
Gender IMIFI 54/18 1817 
Age 16-86161) 23- 81 161 I 
Cardiac history 6 3 
Pulmonary history 8 2 
H2-Biockers 10 7 
Corticosteroids 12 2 
Tracheostomies 13 8 
Acute admissions 29 19 
Diagnostic categories 
Oesophageal resection 39 4 
Trauma 12 6 
Aneurysm repair 9 6 
Septicaemia 5 4 
Pancreatitis 2 
Pneumonia 2 
Neurological 1 1 
Miscellaneous 2 4 
Infections on lCU-admission 10 7 
Apache II day 0 12- 42 1231 19-34 + 1251 
day 1 12- 35 1231 20-35 1251 
SO-medication, days 2-881161 3-76 1201 
No of patients starting SD, 
before ICU-admission #, 28 1 
on ICU-admission, 28 7 
after !CU-admission @, 16 17 
SD 
' 
Selective decontamination 
ICU 
' 
Intensive Care Unit 
Mean values between brackets. 
Chi-square test, p = 0.004 
+ Unpaired T-test, p = 0.042 
# Chi-square test, p = 0.003 
@ Chi-square test, p = 0.001 
Bacteriology and definitions 
On admission, inventory cultures were taken from the nose, throat, sputum, urine 
and rectum, and repeated weekly, while other cultures were taken on indication. 
Identification of pathogenic micro-organisms and testing for antibiotic sensitivity 
was done according to standard laboratory techniques. Definitions are given in 
chapter 2, pp 35. Resistance to the antibiotics used in the regimen was recorded 
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during the study and related to the number of patients colonized with resistant 
micro-organisms. 
Statistics 
Comparison of data between two study-groups was done by application of the Chi-
square test (with Yates correction) and Fisher's exact test for small numbers. Mean 
values with close-to-normal distributions were compared by the unpaired t-test, 
not-normal or skewed distributions (range and median value given) by the Mann-
Whitney U-Wilcoxon rank sum W test. Differences were considered significant 
when p-values were less then 0.05 (t-test, Mann-Whitney, Chi-square and two-
sided Fisher's test). 
6.3 Results 
Of the 135 patients receiving selective decontamination, 38 (28%) came from 
other hospitals. Because of possible "lead-time bias"28 these transferred patients 
were excluded from this study. 48 of the remaining 97 patients were acutely 
admitted to the ICU whereas 49 underwent elective surgery. 
Medication and rate of decontamination 
Of the 97 patients with selective decontamination, 90 had no aerobic pathogenic 
micro-organisms in the oropharynx or rectum upon admission to the ICU, 5 patients 
were decontaminated within 3 days after ICU-admission. Of the 97 patients 
receiving selective decontamination, 72 remained successfuHy decontaminated 
during their admission whereas decontamination failed in 25 patients (26%). 
Bacteriology is given in Table 6.2. The success of decontamination was related to 
the moment of commencement of selective decontamination, 28 of the successful-
ly decontaminated patients received the medication already preoperatively against 
1 of the unsuccessfully decontaminated patients (39 vs. 4%, p = 0.003). A 
postoperative start of selective decontamination was seen in 16 successfully and 
17 unsuccessfully decontaminated patients (22 vs. 68%, p = 0.001, Table 6.11. 
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Table 6.2 Colonization in oropharynx and rectum 
Failed ~§contaminatiQn 
Admission Elimination Pgrsi§J:§nce A!;;:gyirg~ 
Q B. Q B. Q B. Q B. 
Total 48 32 40 24 8 8 32 18 
Gram-negaiive sgecies 
Escherichia Coli 17 7 15 5 2 2 4 1 
Klebsiella 9 2 8 2 1 1 
Enterobacter 3 4 2 4 5 2 
Serratia 2 
Proteus 5 4 4 1 
Pseudomonas 4 4 3 1 3 4 5 
Citrobacter 2 2 2 2 1 
Acinetobacter 3 
Branhamella 
Gram-gositive s~t:ecies 
S.aureus 4 3 3 
MRSA 2 
MRSE 1 
Enterococcus 3 
Str.pneumoniae 
C. albicans 7 4 5 3 2 2 
0 Oropharyngeal colonization 
R Rectal colonization 
Acquired: Micro-organisms acquired during selective decontamination 
MRSA Methicillin resistant Staph.aureus 
MRSE 
' 
Methicillin resistant Staph.epidermidis. 
Prophylactic systemic antibiotics were given for 24 hours peri-operatively in 86 
patients and in 11 patients as a treatment regimen already pre-operatively because 
of suspected infections. There were no significant differences in this aspect 
between groups with successful or unsuccessful decontamination (7 vs. 4 
patients). 
Table 6.1 shows the relevant parameters of the 72 successfully and 25 
unsuccessfully decontaminated patients. Although the group not achieving 
successful decontamination had higher APACHE II scores and more acute 
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admissions their predicted mortality-rates were similar to the group with successful 
decontamination (40 resp.44%), indicating a comparable "severity-of-illness". 
Table 6.3 Infection sites related to the success of selective 
decontamination 
Infected patients 
Pneumonia 
Pleural empyema 
Mediastinitis 
Abdominal abscess 
Urinary tract 
Septicemia 
Pancreatic necrosis 
Wounds 
Miscellaneous 
so 
Chi-square test 
Successfu! SO (72J 
28139%1 
6 
4 
6 
15 
2 
10 
1 
Unsuccessful SO !251 
25. (100%1 
13. 
2 
6+ 
11 # 
16 # 
4 
2 
Selective decontamination 
•: p < 10-:>, +: p = 0.017, #: p < 0.000 
Infection-rates and antibiotic days 
Of the 97 patients 53 (55%) developed 105 infections of which 71 (68%) were 
gram-negative or mixed in origin. It is important to note that a!l infections were 
nosocomial although 17 patients had 19 infections on admission to the !CU. Of 
these patients, 9 had deep abdominal or soft tissue abscesses on !CU-admission 
and in 5 of them selective decontamination successfully prevented colonization of 
the oropharynx and gut by the gram-negative micro-organisms already present in 
the abscesses. All 25 patients with unsuccessful decontamination (100%) and 28 
of the 72 successfully decontaminated patients (39%) suffered from nosocomial 
infections (Table 6.3). In the successfully decontaminated group not only a 
significant decrease was observed in the number of lower respiratory tract 
infections, but also in the number of urinary tract infections, abdominal abscesses 
and septicemia. All these infections were less frequently gram-negative in origin in 
the adequately decontaminated group compared to failed selective decontamination 
(53 vs. 80%, p = 0.006, Chi-square). The bacteriology is given in Table 6.4. 
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Table 6.4 Bacteriology of infections 
Successful SO UnsuJ;;cessf!,!l §!D 
f 1! w .§. 6 f 1! w .§. 6 
Gram-negative SQecies 
Escherichia Coli 3 3 3 3 1 3 2 5 
Klebsiella 2 2 2 1 
Enterobacter 2 2 1 2 2 
Serratia 2 1 1 
Proteus 2 3 
Morganel!a 
Pseudomonas 3 5 4 
Citrobacter 1 1 
Acinetobacter 2 2 2 
Branham ella 1 
Gram-gositive sgecies 
S.aureus 1 1 4 
$.epiderm. 4 2 2 1 2 
MRSA 
MRSE 1 3 1 7 4 
Enterococcus 2 2 2 3 2 3 6 
Str.pneumonlae 2 
Anaerobes 4 2 3 
SD: Selective decontamination, P: Pneumonia, U: Urinary tract infection, W: Wound 
infection, S: Septicemia, A: Abscess 
Str. : Streptococcus 
S. : Staphylococcus 
MRSA : Methicillin resistant S.aureus 
MRSE : Methicillin resistant S.epidermidis. 
The use of systemic antimicrobial agents, therapeutic as well as those used 
in the prophylactic regimen, was significantly lower in the group with successful 
decontamination, as expressed by the number of antibiotic days (Table 6.5). During 
this study 2828 of 6680 sampled cultures showed growth of which 42% proved 
to be gram-negative. 5 primary admitted patients (5%) were colonized with 5 
resistant gram-negative strains, 1 mu!tiresistantAcinetobacterand 4 Pseudomona-
ceae resistant to norfloxacine(3), tobramycin(3) and co-clavulanicacid/ticarcillin(2). 
Table 6.5 Mortality, duration of stay. ventilation and antibiotic days 
Successful SO (721 Unsuccessful SD f25l 
Ranoe ~ Me ± St Range ~ 
Duration of stay 
Total 7-195 24 34 ± 31 
ICU 1- 94 7 9 ± 13 
Ventilation 
Total 1-87 3 7 ± 12 
Tracheostomy 1- 87 16 21 ± 23 
Antibiotic days 0- 85 4 12 ± 18 
Infectious mortality : 5 
Actual mortality 13 
Predicted mortality 30 
17%1 
(18%) ** 
(40%) ** 
SD : Selective decontamination 
Me± St : Mean ± Standard Deviation 
Mann-Whitney test, p = 0.002 
+ Mann-Whitney test, p < 0.000 
# Fisher's exact test, p = 0.030 
7-130. 44 
3-65 + 18 
1-40 + 12 
3- 39 31 
0-106 + 20 
6 
11 
11 
# 124%1 
@ 144%1 
144%1 
@ Chi-square test; successful vs. unsuccessful SD, p = 0.020 
Me± St 
52± 35 
23 ± 16 
17 ± 13 
25 ± 14 
25 ± 24 
Chi-square test; predicted vs. actual death-rate, successful SO, p = 0.006 
Ventilation, duration of stay and mortality 
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The mortality observed in the total group of patients was 25% [24 of 97 patients), 
7 due to septicemia and 4 to multiple organ failure [11% infection-related 
mortality). Actual mortality was significantly correlated to the success of selective 
decontamination; 18% in the group with successful decontamination and 44% in 
the unsuccessfully decontaminated patients [p = 0.02, Table 6.5), non-infectious . 
mortality was 11% resp. 20% whereas the infection-related mortality was 7 resp. 
24% [p = 0.03). Predicted death-rates were similar in both groups [40 vs. 44%), 
the actual death-rate was accurately predicted [calculated) in the unsuccessfully 
decontaminated group [44%) but significantly lower compared to the predicted 
mortality-rate in the group with successful decontamination [18% actual vs 40% 
predicted, p = 0.006, Table 6.5). 
In the successfully decontaminated group significantly less days of ICU- and 
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hospital-admission and ventilation days were recorded (Table 6.5). This group 
however included more elective patients, who have significantly shorter ventilator-
periods compared to acutely admitted patients (4 vs 16 days, p = 0.000). 
6.4 Discussion 
This study reports a significant decrease in mortality and the length of ICU- and 
total hospital-stay in surgical patients receiving selective decontamination but only 
when successful decontamination has been reached. This significant decrease was 
seen in the actual mortality rates but more importantly by comparing actual with 
predicted death rates in the successfully decontaminated group in contrary to those 
unsuccessfully decontaminated, indicating a beneficial effect of successful 
decontamination. Predicted rates were furthermore comparable between both 
groups despite the difference in APACHE II or the number of acute patients, 
indicating the comparability in terms of "severity of illness". Predicted mortality-
rates calculated this way are superior to APACHE or SAP scores in predicting 
outcome because these rates account for different diagnostic categories and acute 
admissions, factors which are not incorporated in the Apache II- or SAP score. 
However, there can be an important influence of the APACHE II scores used to 
calculate predicted rates when these scores are determined directly postoperative. 
Possible hypothermia with hyperglycaemia, low potassium levels, elective 
ventilation and reduced base excess will greatly influence the total score, which 
will stabilise on lower values when the direct postoperative stress has subsided. 
Analysis of the APACHE scores determined on ICU-admission and the next day 
revealed however no differences between these two values (Table 6.1 ). We 
therefore think the observed decrease in (infection-related and total) mortality is the 
result of a beneficial effect of selective decontamination. 
Recently, Gastinne et al.25 reported in a study of 445 patients on multiple 
intensive care units that selective decontamination had no significant effect on 
mortality or the length of stay in the ICU. Their study however concerned the 
general effect of selective decontamination in predominantly medical patients. 
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Considering the influence of "diagnostic categories" their conclusions are confined 
to medical patients only. In the present study, the recognition of a group of 
surgical patients receiving selective decontamination but not achieving successful 
decontamination (almost one-quarter of all patients) proved to have important 
consequences for the outcome of these patients. Whether the failed decontamina-
tion in this subgroup of patients is a reflection of their altered peristalsis and 
subsequently of their altered colonization resistance remains unanswered and may 
be an epiphenomena leading us to those very ill patients not responding to any 
therapy. This finding of inadequate decontamination might also explain why earlier 
studies failed to demonstrate a beneficial effect of this prophylaxis on mortality and 
admission. 
As we have shown previously the success of selective decontamination is 
high when administered elective and pre-operatively9• Accordingly, electively 
admitted patients appear to benefit most. SO-medication started after ICU-
admission is less effective in achieving decontamination and consequently does not 
reduce the risk of developing a lower respiratory tract infection. A possible 
correlation between unsuccessful selective decontamination and an acute 
admission remains to be determined, and future study of these subgroups can 
possibly predict risk-factors associated with unsuccessful decontamination, so that 
efforts can be made to eliminate these factors and prevent failure.ln contrast to the 
previous study, we used norfloxacine instead of tobramycin in the antibiotic 
regimen, merely because it appeared equally effective in selective decontamina-
tion•, but at a much lower expense. 
In conclusion, the present study has shown that patients in whom selective 
decontamination is successful greatly benefit from its administration as is 
expressed by the reduction of actual mortality in comparison to calculated 
mortality. However if selective decontamination fails to eliminate all gram-negative 
micro-organisms from the alimentary tract, patients have a high risk to develop 
infections and to subsequent death. This group of patients is prone to have 
prolonged use of antibiotics and longer ICU- and hospital-stay. Studies to identify 
the cause of failure to decontaminate these patients successfully need to be 
undertaken. 
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7.1 Introduction 
Selective decontamination {SDI is a method to prevent infections based on the 
concept of enhancing colonization resistance {CRI, as one of the most important 
defence-mechanisms of the host against colonization and infection,_2 • CR consists 
of a physiological and a microbiological part'~, in which the anaerobic flora exerts 
an important role. The non-absorbab!eantibiotics used in selective decontamination 
try to preserve this endogenous flora, and thereby the valuable ecological 
equilibrium. The effects of selective decontamination on gram-negative colonization 
and infections have been studied extensively&-.,.2 and have been communicated in 
recent reviews 13- 14 • The principal conclusion presented in most studies is that gram-
negative colonization and infections are prevented but effects on mortality are 
inconclusive. 
We recent!y described the successful prevention of gram-negative colonization and 
infections using selective decontamination perioperatively in 56 patients in the 
surgical intensive care unit {ICU). After discontinuation of the SO-regime on the 
tenth day we observed a worrisome rebound colonization with gram-negative 
micro-organisms in 23 patients {41 %1. of which 4 {7%) developed 12 infections". 
No infection was caused by antibiotic-resistant micro-organisms {chapter 4). 
Apart from one observation in mice 16 this rebound colonization has not been 
reported in clinical applications. Moreover, besides this direct effect on endogenous 
infections, the risk of these colonized patients being a source of resistance and 
infection is a realistic danger17•18 and has important epidemiological consequences. 
Especially the ICU has the conditions to enhance the acquisition and spread of 
epidemic multiresistant strains 19 and since these possibly resistant micro-organisms 
colonizing the host can persist as "resident f!ora" for years following hospitalisa-
tion20 they can endanger the !CU- and hospital environment in subsequent 
admissions. !Hustrative in this respect ls that as many as 44°/o of all patients 
colonized with Pseudomonaceae and 81% of those with Staphylococcus aureus 
show these micro-organisms already on admission to the ICU and are therefore 
apparently previously acquired; these patients also experience more infections 
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caused by these bacteria than patients not colonized {50 vs 20%, resp. 13 vs 
8%) 21 • Because of these hazardous clinical implications it is important to protect 
patients from getting colonized, whether during or after SO-medication. 
We decided to conduct a prospective cohort-study to evaluate the 
microbiological consequences in patients during and following the use of SO-
medication to detect {un-)successful decontamination, possible rebound coloniza-
tion with persistent, previously eliminated and/or newly acquired strains, infectious 
complications and resistance. We also tried to determine the period after which SO-
medication can be safely withdrawn. In addition we studied the possible 
epidemiological effects of the transfer of SO-medicated patients from the ICU to 
the ward. 
7.2 Patients and methods 
Patients 
Patient-populations with the greatest benefit from receiving SO-medication were 
identified according to earlier experience15 , and based on existing literature7·12"13 
which seems to restrict the indication to surgical patients. All surgical patients 
undergoing elective operations with an increased risk of pulmonary infection, with 
subsequent ICU admission were therefore given SO-medication in combination with 
a mechanical bowel preparation three days prior to the operation, and included in 
the study. Patients acutely admitted to the ICU with multiple trauma who were 
expected to be intubated and ventilated for more than 4 days, those with 
complications after previous surgery and all patients with acute necrotising 
pancreatitis also received SO-medication and were likewise included. No permission 
from the Ethical Committee was needed since this application of selective 
decontamination is institutionalised in our hospital as a result of the previous 
study15 • 
Between November 1989 and May 1991, 135 patients in oursurgicaiiCU received 
SO-medication during 154 ICU-admissions {there were 19 re-admissions). For this 
107 
cohort-study, we evaluated each definite episode in which a given patient (either 
primarily admitted or transferred) received SO-medication because we were 
principally interested in epidemiological processes and not in differences between 
patients. Accordingly, despite the selection-and lead-time bias22 we included all 
transferred patients because we thoughtthem to be interesting patients to evaluate 
in comparison to primarily admitted cases. All patients were scored according to 
the Apache II system when admitted to the ICU23 • 
Oesophageal resections were done by blunt transhiatal dissection via an 
upper median laparotomy, reconstruction followed by a stomach-tube with a 
cervical anastomosis. Thoraco-abdominal resections of aneurysms were done via 
a left-sided thoraco-abdominal incision including the left diaphragm; patients with 
an acute pancreatitis were operated only when a clinical deterioration appeared 
from infected necrosis. 
Medication and bacteriology 
SO-medication consisted of Ora base" containing 2% of polymyxin E, amphotericine 
Band norfloxacine applied 4 times daily on the buccal mucosa and tracheostomy-
sites and an enteral suspension of the same antimicrobial agents (200, 500, 50 mg 
respectively) given by mouth, nasogastric tube or needle-jejunostomy also 4 times 
a day (chapter 6, pp 91 ). 
On admission to the ICU (acutely admitted patients) or ward (elective 
patients), inventory cultures were taken from the nose, throat, sputum, urine and 
rectum; thereafter once a week while other cultures were taken on indication. On 
operation-day new cultures were obtained from patients undergoing elective 
procedures. Again inventory cultures were taken 5 days after discontinuation of 
SO-medication. Identification of pathogenic micro-organisms and testing for 
antibiotic sensitivity was done according to standard laboratory techniques. 
Definitions were as described in chapter 2, pp 35. Resistance to the antibiotics in 
the regimen was recorded during the study in all cultures including the first 
inventory- and surveillance-cultures; for epidemiological purposes additional cultu-
res were taken and especially those strains responsible for a rebound colonization 
were tested on their antimicrobial sensitivity especially versus the SO-antibiotics. 
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Statistics 
Whenever applicable, differences between groups of patients were compared by 
the Chi-square test (with Yates-correction) and the two-sided Fisher's exact test 
for small numbers. Mean values with close-to-normal distributions were compared 
by the unpaired t-test, not-normal distributions by the Mann-Whitney U-Wilcoxon 
rank sum test. Differences were considered significant when p-values were less 
than 0.05. 
7.3 Results 
During this study 135 patients were evaluated in 154 episodes of selective 
decontamination, their characteristics and admission-diagnoses are given in Table 
7.1 and 7.2. 
Table 7.1 Patient characteristics 
GenderiMIFI 
Age 
Apache II 
Admission 
Total 
ICU 
Ventilation 
SD 
Successful 
Antibiotic days (syst) 
Mortality 
Mean values between brackets. 
SD : Selective decontamination 
Syst : Systemic use of antibiotics 
103/32 
16-86 1611 
12- 42 1241 
6-236 
1- 99 
1- 87 
2- 98 
92 
0-119 
35 
1461 
1181 
1141 
1201 
168%1 
1221 
126%1 
Considering the introduction of selection-bias and the "degree of illness"22•23 there 
was an anticipated influence of transferred and re-admitted patients on overall 
figures; compared to primary admitted patients they were significantly more often 
unsuccessfully decontaminated (47 vs 26%, p =0.02) and had higher APACHE II-
109 
scores (mean 26 vs 24, p =0.02); they also had longer ventilator-periods, total-
and ICU-admissions and more antibiotic days (all p<O.OOO, Mann-Whitney). 
Table 7.2 Diagnoses on admission 
Elective: 
Acute: 
Totat 
R.L 
M.O.F. 
Oesophageal resection 
Vascular surgery 
Trauma 
Peritonitis 
Pancreatitis 
Mediastinitis 
R.I. 
M.O.F. 
Mesenterial thrombosis 
: Respiratory Insufficiency 
: Multiple Organ Failure 
44 
19 
23 
19 
10 
7 
4 
5 
4 
-- + 
135 
In 78 of the 154 episodes with SO-medication 173 strains of potentially 
pathogenic micro-organisms (PPM) were cultured upon admission, 99 of these 
strains were obtained from transferred patients in 28 periods. In 19 of the 78 
episodes, patients had distinct, localised foci of infection such as abdominal 
abscesses or pleural empyema which harboured 30 strains, 19 ofthese were gram-
negative. The remaining 76 of 154 episodes revealed non-pathogenic flora in 
cultures from oropharynx and rectum. 
Efficacy of selective decontamination 
Selective decontamination could not be achieved in 19 episodes and failed to 
protect against colonization during this prophylaxis in 30, thus resulting in 49 
unsuccessfully decontaminated episodes, a failure-rate of 32%. 
The bacteriology is captured in Table 7.3 and 7.4; 64 resp. 79% of the 
gram-negative pathogenic micro-organisms could be eliminated from the 
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Table 7.3 Oropharyngeal colonization 
During SD After SO 
Admi Elim Pers 8£ru! Reap New Not 
Total 59 39 20 23 2 16 15 
Gram-negative species : 39 25 ll 1Z ..2. lQ 12. 
Escherichia Coli 11 8 3 1 
Klebsiella 2 2 2 3 2 
Enterobacter 5 5 3 3 2 
Serratia 2 2 2 
Proteus 1 1 1 
Pseudomonas 12 4 8 8 2 5 
Citrobacter 2 2 
Acinetobacter 1 1 2 
Branhamella 2 2 
Haemoph.influenzae 1 
Gram-positive species 12. ~ .± _§_ ..: .2 ..2. 
s.aureus 7 4 3 2 
S.epidermidis 1 1 
MRSA 2 
MRSE 
Enterococcus 1 1 
Str.pneumoniae 2 2 
C.albicans ~ ~ ..2. ~ ..: .2 ~ 
Admi = Admission, Elim = Elimination, Pers = persistance, Acqu = Acquisition, 
Reap= Reappearance, New= Newly cultured, Not= Not cultured 
Haemoph.: Haemophilus, S.: Staphylococcus, Str.: Streptococcus, C.: Candida 
oropharynx (Table 7.3) and rectum or stool (Table 7.4). The persistence of 8 
Pseudomonaceae and the methicillin resistant S.aureus (MRSAJ in the oropharynx 
is an important observation, because 6 of these strains were cultured from 
transferred patients. During the 30 unsuccessful episodes 5 fungi, 56 gram-
negative and 13 gram-positive strains were acquired including multiresistant strains 
of S.aureus (5) and S.epidermidis (2). In 14 of the 19 episodes in patients with 
infectious foci selective decontamination prevented further spread of these micro-
organisms to oropharynx or gut. 
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Table 7.4 Recta! colonization 
During SD Afier §!D 
AQmi Elim ~ 6£ru! Bm!l! New !lim; 
Total 84 64 20 51 12 44 20 
!:aram-negative s12ecies 70 ~ 1.§ 39 J! 28 1.§ 
Escherichia Coli 27 22 5 8 4 10 2 
Klebsiella 11 10 1 2 3 7 1 
Enterobacter 8 6 2 7 4 4 
Serratia 3 
Proteus 9 7 2 5 3 
Pseudomonas 11 7 4 9 3 3 
Citrobacter 2 2 1 4 
Acinetobacter 2 4 2 
Qram-gositive SQecies 
.1. ..! ..! ..§. .1. 1.§. ..± 
s.epidermidis 6 
MRSA 3 
MRSE 1 
Enterococcus 2 4 10 
C.albicans g ..§. 
..± ..± ..! ..: ..! 
Admi = Admission, Elim = Elimination, Pers = persistance, Acqu = Acquisition, 
Reap= Reappearance, New= Newly cultured, Not= Not cultured 
S.: Staphylococcus, C.: Candida 
A possible reason for unsuccessful decontamination was the inadequate use 
of SO-medication in 20 episodes, in which amongst others the oropharyngeal paste 
was omitted in 2 and not applied around the tracheostomy in 3 episodes. Selective 
decontamination was inadvertently ceased for a short time in another 2 episodes 
but with the renewed start PPM could again be eliminated in both patients. In 11 
episodes SO-medication was initiated too late, in 2 it was applied too short. Other 
failures occurred in episodes where patients suffered from primary respiratory 
insufficiency (5). were unconscious or had other neurological injuries (10). had a 
bronchopleural (1) or oesophagotracheal (1) fistula or had to be reintubated (3). In 
9 episodes no possible interrelated conditions could be recovered. SO-medication 
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was discontinued because of these failures in 7 episodes (5%), including 4 because 
of colonization with resistant micro-organisms. In 3 other episodes colonization 
with a MRSA followed after the introduction and spread of this strain by a 
transferred patient, SO-medication was however not discontinued to protect these 
patients from further gram-negative colonization. 
Rebound colonization 
Inventory cultures following the withdrawal of SO-medication could be obtained in 
90 of the 105 successful episodes and in 33 of the 49 unsuccessful episodes, the 
remaining 31 were not available because of mortality during the period that 
selective decontamination was administrated (24 patients) or premature discharge 
before cultures could be done. Of these cultures, 20 out of 90 successfully 
decontaminated episodes (22%) showed rebound colonization with pathogenic 
micro-organisms. Out of the 33 unsuccessfully episodes 19 showed the same 
micro-organism that was responsible for the colonization during the period of 
administration of SO-medication while 14 (42%) revealed no growth of PPM. Thus, 
in 84 of the 123 episodes (68%) a complete colonization with pre-admission 
strains was encountered. 
The microbiological features are shown in Table 7.3 and 7.4; noteworthy is 
that 2 (8%) of all gram-negative bacilli eliminated from the oropharynx and 9 
(16%) of those from the gut reappeared in these cultures. Furthermore, 16 
oropharyngeal and 44 rectal strains were newly cultured. On the contrary, 12 of 
31 gram-negative strains persisting or acquired in the oropharynx (39%) and 15 
of 54 rectal strains (28%! were no longer cultured. There were no infections due 
to rebound colonization. 
Resistance 
On admission 4 transferred patients had 7 resistant micro-organisms in their 
inventory cultures, of which 6 persisted. During the use of selective decontamina-
tion, colonization with 25 resistant strains was encountered in 13 episodes (1 0%). 
These strains included 4 originally sensitive Pseudomonas and 1 Klebsiella sp. 
which developed resistance to norfloxacine (3). tobramycin (2) and co-clavulanic 
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acid/ticarcillin (3). 7 periods failed solely because of this resistance, in 4 the SO-
medication was discontinued. Resistant micro-organisms were the cause for 10 
superinfections. In 11 of these 13 episodes no resistant strain could be recovered 
in the epidemiological cultures after selective decontamination, in 2 they continued 
to be present. 
Epidemiological evaluation of 119 positive cultures from 82 patients revealed 8 
patients (9,8%) with 10 strains resistant to aminoglycosides (7), third generation 
cephalosporins and aminoglycosides (2) and quinolones (3), as well as 3 MRSE and 
2 MRSA strains. 6 of these 8 patients showed newly cultured resistant bacteria 
while 2 were patients from the 13 who already acquired resistance during SO, 
showing the same resistant micro-organism. 
7.4 Discussion 
In the present study rebound gram-negative colonization following discontinuation 
of SO-medication was encountered in 22% of the successfully decontaminated 
patients without serious infections, while a 10% resistance-rate was found. 
Rebound colonization with gram-negative micro-organisms can be potentially 
hazardous in granulocytopenic patients who are totally decontaminated, as 
described in the haemato-oncological iiterature3·24-25 . These immunocompromised 
patients lack an adequate (microbiological) colonization resistance, so unopposed 
bacterial acquisition after discontinuing atl antibiotics will easily result in life-
threatening colonization and infection. Theoretically, this should be a minor 
problem in selective decontamination, because the indigenous anaerobic gut-flora 
thought responsible for colonization resistance is unaffected and therefore prevents 
an overgrowth with aerobic gram-negative bacilli. However, rebound colonization 
after discontinuation of SO-medication has been described in mice by Speekenbrink 
and colleagues16, who reintroduced mice after discontinuation of SO-medication in 
an untreated population. They saw a substantial increase in total aerobic counts 
in treated but also in untreated mice. Previously, we found a substantial gram-
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negative colonization (41% of patients) following the withdrawal of SO-medication 
in patients with late complications after oesophageal resection and 
reconstruction", resulting in 3 gram-negative respiratory tract infections. Probably 
the discontinuation of SO-medication indiscriminately 10 days after surgery 
irrespective oft he patients condition and thereby ignoring the important detrimental 
effect of trauma and illness on the defence-mechanisms",.31 promoted these 
infectious complications. We extended the period of SO-medication arbitrarily to 
5 days after extubation when the normal defences against colonization (normal 
swallowing and coughing reflexes, ability to have oral intake with normal peristalsis 
and adequate mobilisation) were presumed to be restored, with the described 
improved results: most patients regained their "normal" flora (recolonization) while 
even micro-organisms persisting during selective decontamination have disap-
peared. Consequently, the danger of these patients being reservoirs of nosocomial 
pathogens for years after hospitalisation seems to be less dangerous than 
described by others1a-20 • In contrast to the increase in resistance to cefotaxime 
found by Eastaway32 our resistance-rate of 10% in cultures after SO-medication 
is in accordance with the 8% found in control-patients during the previous study' 5• 
This resistance should however be subject of constant surveillance since it was still 
the cause for 7 failures. 
An interesting aspect is the reappearance of several micro-organisms after 
the discontinuation of SO-medication indicating only a suppression of micro-
organisms (no elimination) and that oropharyngeal decontamination seems to be 
difficult. This is perhaps due to the presence of foreign material (endotracheal and 
nasogastric tubes) or to the possible difficulties to bring the active antimicrobials 
to their place of action; the mucosa. Also the problem of possibly resistant micro-
organisms persisting in transferred patients is actual. and stresses the importance 
of infection-control practice also after surveillance-cultures are known. 
In conclusion, rebound colonization after withdrawal of SO-medication seems 
to offer no problem when the medication is continued until 5 days after extubation 
in patients with adequate decontamination. This indicates an intact and functional 
colonization resistance after cessation of SO-medication which prevents the patient 
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from persistence or new acquisition of resistant strains: the pre-antibiotic 
endogenous flora is restored in most patients. We advice to stop SO-medication 5 
days after extubation when the normal defence-mechanisms are presumed to be 
restored. 
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8.1 Introduction 
Selective decontamination, at first applied to reduce the number of fever periods 
in patients with granulocytopenia', has been in the centre of interest in intensive 
care medicine since the application of this prophylactic regimen in trauma patients 
by Stoutenbeek and colleagues2 • They described promising results, however in a 
study using historical, consecutive controls. This base-line study raised several 
questions, amongst others what influence was present from the systemic 
antimicrobials in this regimen3 , an item stiH the cause for continuing debate. To 
solve this, as well as questions concerning the efficacy of selective decontamina-
tion in reducing infectious complications in certain patient groups, several studies 
were conducted in the mid-80's. The main problem in these studies was the 
heterogeneity in patient groups, a problem particularly true for patient populations 
in the intensive care unit. 
We identified the group of patients with oesophageal carcinoma, admitted 
to have a one-stage resection and reconstruction as such a homogeneous group 
of patients and decided to enrol them in a prospective, randomised study4 since 
they have high risk to develop postoperative pulmonary tract infections (chapter 
1 ). The selection ofthis patient group rendered several additional advantages when 
compared to other studies using mixed patient groups. Firstly we were able to 
install selective decontamination already pre-operatively because of the elective 
procedure, thus resulting in an effective decontamination on the day of operation 
in 93% of the patients (chapter 5). As a consequence we could discontinue all 
systemic prophylactic antibiotics directly upon admission to the ICU, knowing that 
this part of the prophylaxis was intended to treat possible incubating "community 
acquired" infections and to prevent colonization during the first days in which 
selective decontamination is not yet installed2 • This has important epidemiological 
consequences because antibiotic pressure on the ward with the highest risk on the 
transfer of resistance5•7 is consequently diminished. Results showed a highly 
significant decrease in antibiotic days in patients with successful selective 
decontamination, including both prophylactically and therapeutically used 
antibiotics (chapter 6). Moreover a 50% reduction was found in the number of 
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patients receiving therapeutic antibiotics (chapter 4). Accordingly, no increase in 
resistance was encountered during the last 6 years of experience with selective 
decontamination (chapter 5 and 7). 
8.2 Selective decontamination and morbidity 
The first prospective, randomised study published was that of Kerver and 
colleagues•. They studied mechanically ventilated surgical patients, predominantly 
those admitted after multiple trauma, and reported a significant decrease in the 
number of pulmonary tract infections and intra-abdominal abscesses, as well as in 
the number of septicemias. We found beneficial effects in major elective surgery 
(chapter 4), and until now at least 14 randomised studies•.a.zo of which 5 have 
been conducted in a double blind, placebo controlled design11"13·' 6•20 have reported 
a statistically significant decrease in gram-negative colonization and infection rates 
in the group with selective decontamination (chapter 3). On the contrary, 4 other 
randomised studies21 •24 (3 were double blind, placebo controlled21 ·"'24l could not 
find such a beneficial effect of this prophylaxis, although both Hammond and 
Gastinne2a-24 did find a significant decrease in the number of gram~negative 
infections in their study group. The absence of an overall effect is probably at least 
partly due to the population studied, since most of the studies which reported 
benefit showed a majority of surgical patients in both groups, while 3 of these 4 
inconclusive studies included predominantly medical patients. The fourth study21 
did show a decrease in the number of (gram-negative and gram-positive) infections 
as well as in the number of infected patients using norfloxacine and nystatin 
enterally, but this could not reach significance possibly because their surgical 
patient group was small and very heterogeneous. Although this heterogeneity 
applies for almost every study being conducted in the ICU, the influence of 
diagnostic categories on outcome25 has probably more implications for the 
comparability between groups in studies with a variety of medical or neurological 
admissions, such as the studies of Gastinne et al.23 and Hammond and collea-
gues24. The study of Gastinne23 was furthermore a multicentre one and included 
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44 resp. 45% transferrals in both groups, which is an extra factor compromising 
comparability. Patients in both groups in the study of Hammond et al.24 additionally 
received parenteral cefotaxime for 72 hours, which can possibly dilute an effect 
of selective decontamination. This illustrates that not only the patient population 
but also the used regimen should always be taken into account when studies are 
to be designed. Nevertheless, despite the shortcomings in design of several studies 
there may be an existent difference between surgical and medica[ patients which 
is responsible for the different effects on infection rates. 
The increase in gram.positive colonization using selective decontamination 
has until now not been followed by an increase in gram-positive infections, except 
for the studies of Gastinne23 and Hammond24 . When apparent, these infections are 
however easily treated with current antimicrobiats. 
8.3 Selective decontamination and mortality 
Effects of selective decontamination on survival are not near!y as pronounced as 
effects on morbidity (chapter 3). One known study with mortality as an endpoint 
was that of Gastinne et al.22 which could not detect any effect of selective 
decontamination but had several drawbacks in design (paragraph 8.2), and another 
study20 showed a significant decrease in overall and infection related mortality. 
They however encountered a considerable increase in resistance against 
cefotaxime and tobramycin. Blair17 applied pre-randomisedstratification to APACHE 
II scores, and saw a decrease in mortality in the SO-medicated group with scores 
between 10 and 19 which was nearly significant (p=0.071. One historicai26 and 
two randomised 9•14 studies showed a significant decrease in overall mortality 
although the results in the former26 were obscured by the simultaneous use of H2-
blockers and sucralfate in different subgroups, and in the Ulrich study9 antibiotics 
were given already when colonizaf1on was encountered in SO-receiving patients 
only. Other studies did find beneficial effects on survival, but only in subgroups 
such as polytrauma27, surgical patients with infections8 or septicemia9 , with long 
term ICU~admission11 , or undergoing cardiac surgery12.1t is however striking that 
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most studies reporting an effect on survival regard surgical patients. Effects in 
medical patients are until now not evident, possibly because of the influence of 
their underlying illness on mortality28 • 
Why should mortality be unchanged when effects on morbidity are so profound, 
remembering the close relationship between infections and mortality? Since 
mortality in our group of oesophageal resections was only 5%, no conclusion on 
mortality effects could be drawn from our first study (chapter 4). To clarify this 
problem, we conducted a follow up study in which we identified a group of 
patients receiving selective decontamination without success, experiencing more 
infections, higher mortality and longer admissions compared to successfully 
decontaminated patients (chapter 6). We thought that this could be a possible 
explanation for the obscurity in mortality effects of selective decontamination. We 
also recognised that no study until then could include enough ICU admitted 
patients with homogeneous disease to detect possible effects of selective 
decontamination on survival in a randomised study. At the first international 
consensus conference in Paris29 , it was calculated that at least 2000 patients were 
needed in each treatment arm to detect such a difference, given a baseline 
infection related mortality of 30-35% and a 10-20% effect of selective decontami-
nation. Interestingly, such a difference was indeed measured in a meta~analysis 
including approximately 4000 patients from 22 controlled randomised studies30 • To 
bypass the problems of heterogeneity and numbers of patients, we thought the 
best way to study the effects on mortality was to characterise all eligible, primary 
admitted patients by calculating their predicted death rate. Until now, this is the 
best known method to characterise patients in terms of "severity of illness" 
(chapter 6) and it can be valuable in determining possible beneficial effects of new 
therapeutic or prophylactic regimen by comparing actual death rates with these 
calculated ones; patients serve as their own controls. 
in both ways, effects of successful selective decontamination on mortality 
were highly significant, and this is therefore a strong indication for the beneficial 
effects of (successful) selective decontamination (chapter 6). The subgroup of 
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patients experiencing unsuccessful selective decontamination on the other hand 
might be responsible for the obscurity in effects on mortality in studies until now 
because they could have diluted effects on overall mortality in the total group of 
patients receiving SO-medication. 
8.4 Selective decontamination; where, how and who 
There is much debate concerning the necessity of the different components in the 
regimen, because different combinations of antibiotics rendered sometimes 
contradicting results. Early studies have used systemic antibiotics to protect 
patients against primary infection3 , while others have reported a significant 
decrease in the frequency of pneumonia with oropharyngeal13 or enteral application 
alone 11 •14• However, there is often no clear information about13, or no difference 
in, the total number of infected patients, or information is incomplete about the 
therapeutic use of systemic antibiotics in the first days". 
Parenteral antibiotics 
We think that parenteral antibiotics other than those used in the routine surgical 
wound prophylaxis on the day of operation are superfluous in our elective surgery 
patients. Selective decontamination in itself can lower the rate of wound 
infections, but is insufficient to abolish them because this prophylaxis can lower 
endogenous gram-negative contamination, influencing the exogenous contamina-
tion only by reducing the number of colonised patients thereby reducing the load 
of PPM. To prevent wound infections, additional measures must be included such 
as systemic antibiotics peri-operative or antibiotics suitab[e for selective decontami-
nation but also reaching efficient tissue-levels such as quinolones31 • Systemic 
antibiotics as an additive in selective decontamination are needed in acutely 
admitted patients only when infections are suspected during the time that SD is 
not yet established. Konrad et al.32 proposed a throat swab to determine whether 
systemic antibiotics were needed; these were given when PPM's were cultured. 
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Oropharyngeal and enteral antibiotics 
The oropharyngeal part seems necessary to interrupt the sequence of oropharyn-
geal colonization and subsequent pulmonary tract infections, the enteral compo-
nent is in our opinion needed to prevent the development of resistance in the 
reservoir of micro-organisms in the digestive tract. We oppose to the prophylactic 
use of vancomycin as reported by Pug in 16 because any resistance developing 
against this antimicrobial agent will leave us empty-handed, and gram-positive 
infections are until now of minor concern in our population. 
Selective decontamination, when 
As has been discussed in chapter 4 and 6 it is desirable to start SO-medication as 
early as possible to achieve successful decontamination since these successfully 
decontaminated patients seem to benefit most. This is in accordance with Langer 
et al33 who thought only measures taken in the first days would reduce the 
incidence of ICU acquired pneumonia. SO-medication can be discontinued when 
defences to counteract colonization have been restored (chapter 7) or when 
selective decontamination has failed. 
Surveillance cultures 
Surveillance cultures are in our opinion an essential part of selective decontamina-
tion, not only to detect possible resistance, but even more importantly to see 
whether patients become successfully decontaminated and to guide possible 
therapeutic interventions in the future. 
Selective decontamination~ to whom 
Which patients in the ICU will benefit from selective decontamination and should 
therefore receive this prophylaxis. In the literature, differences seem to be more 
pronounced when surgical patients are studied; in a cross-over study the surgical 
ICU showed better results than the medical ICU12 , and when mortality is used as 
a criterium for effectivity only surgical patients seem to have better survival until 
now'"9· 12·14•17·27 • Patients after trauma and those with long stays in the ICU may 
benefit8 •11 •14•27 , as well as surgical patients undergoing major procedures in which 
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the normal anatomy is altered (e.g. oesophageal resection4 ) or in whom defence 
mechanisms are minimal (e.g. after liver or bone marrow transplantation) so 
complications are apt to occur18·34·35. These patients can have optimal advantage 
by installing selective decontamination already preoperatively. The use of selective 
decontamination in patients who have acute necrotising pancreatitis is currently 
under investigation in a national mu!ticentre trial. 
Can we identify those ICU admitted patients who will be at risk to develop 
infections and will therefore benefit from selective decontamination? This should 
be no problem in patients with known risk factors (chapter 2) but it can be very 
difficult in acutely admitted patients in whom the further clinical course is unclear. 
Moreover, can we identify patients who will fail to become selectively decontami-
nated beforehand? This would offer us the possibility to determine whether a given 
patient will benefit from selective decontamination and, if not, whether these 
apparently very ill patients will respond to any other therapy. Further analysis will 
possibly identify risk factors for unsuccessful selective decontamination and give 
us either manageable features for the prevention of failure, or perhaps provide us 
with a sensitive predictor of survival. 
8.5 Conclusions 
Selective decontamination is a safe method to reduce gram-negative colonization 
and infections in critically ill patients undergoing major elective surgical procedures. 
It is desirable to start SO-medication pre-operative in well-defined patient-groups, 
at risk to develop gram-negative infections because of preexistent risk-factors, or 
as a result of the planned operation. SO-medication can be discontinued 5 days 
after extubation when colonization resistance has normalised, and seems useless 
when selective decontamination has failed. The period of 5 days is chosen on 
clinical grounds and has proven to be satisfactory. When successful selective 
decontamination has been established it is beneficial for the patient in terms of 
morbidity and survival, for the hospital in terms of epidemiology since the overall 
use of systemic antimicrobial agents is significantly decreased, and for the 
community since admission is shorter and costs can be expected to diminish. 
130 
8.6 References 
1. Furth R van,Guiot HFL. Modulation of the host flora. Eur.J.Ciin.Microbiol.lnfect.Dis.8:1-
7, 1989 
2. Stoutenbeek ChP,van Saene HKF,Miranda DR,Zandstra OF. The effect of selective 
decontamination of the digestive tract on colonization and infection rate in multiple trauma 
patients. Intensive Care Med.1 0:185-192,1984 
3. Stoutenbeek ChP,van Saene HKF,Miranda DR,Zandstra DF,Langrehr D. The effect of 
oropharyngeal decontamination using topical nonabsorbab!e antibiotics on the incidence of 
nosocomial respiratory tract infections in multiple trauma patients. J.Trauma 27:357-
364,1987 
4. Tetteroo GWM,Wagenvoort JHT,Castelein A,Tilanus HW,tnce C,Bruining HA. Selective 
decontamination to reduce gram-negative colonization and infections after oesophageal 
resection. lancet 335:704-707,1990 
5. Maki DG. Risk factors for nosocomial infection in intensive care. Devices vs nature and 
goals for the next decade [commentary]. Arch.lntern.Med.149:30-35, 1989 
6. Milatovic D,Braveny !. Development of resistance during antibiotic therapy. Eur.J.Ciin. 
M;crob;ol.6:234·244, 1987 
7. Waay D van der. Colonization resistance of the digestive tract: clinical consequences and 
implications. J.Antimicrob.Chemother.1 0:263-270,1982 
8. Kerver AJH,Rommes JH,Mevissen-Verhage EAE,Hulstaert PF,Vos A, Verhoef J,Wittebo! P. 
Prevention of colonization and infection in critically ill patients, a prospective randomised 
study. Cr;t.Care Med.16:1087-1093,1988 
9. Ulrich C,Harinck-de Weerd,Bakker NC,Jacz K,Doornbos L,de Ridder VA. Selective 
decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired 
infections: a prospective randomised study. Intensive Care Med.1 5:424-431,1989 
1 0. Aerdts SJA. Prevention of lower respiratory tract infection in mechanically ventilated 
patients. [Thesis], 1989,State University Maastricht, The Netherlands. 
11. Godard J,Guiliaume C,Reverdy M-E,Bachmann P,Bui-Xuan B,Nageone A,Motin J. Intestinal 
decontamination in a polyvalent ICU. A double-blind study. Intensive Care Med.16:307-
311,1990 
12. Hartenauer U,Thulig S,lawin P,FegelerW.lnfection surveillance and selective decontamina-
tion of the digestive tract (SDDl in critically ill patients. Results of a controlled study. 
lnfect;on 18 1Suppl.1):22·30, 1990 
13. Rodriguez-Roldan JM,Altuna-Cuesta A, lopez A, Carillo A,Garcia J,Leon J,Martinez-Pellus 
AJ, Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial 
pharyngeal nonabsorbable paste. Crit.Care Med.18:1239-1242, 1990 
14. HOnefeld G.von. Klinische studie zur selektiven darmdekolonisation bei 204 langzeitbeat-
meten abdominal-und unfallchirurgischen intensivpatienten. Anaesthesioi.Reanimat. 14:131-
153,1989 
131 
15. Unertl K,Ruckdeschel G,Selbmann HK,Jensen U,Forst H,lenhart FP,Peter K. Prevention of 
colonization and respiratory tract infections in long~term ventilated patients by local 
antimicrobial prophylaxis. Intensive Care Med.13:1 06-113,1987 
16. Pugin J,Auckenthaler R,Lew DP,Suter PM. Oropharyngeal decontamination decreases 
incidence of ventilator associated pneumonia. A randomised, ptacebo controfled, double 
blind clinical trial. JAMA 265:2704-2710,1991 
17. Stair P,Rowlands BJ,Lowry K,Webb H,Armstrong P,Smitie J. Selective decontamination of 
the digestive tract: a stratified randomised prospective study in a mixed intensive care unit. 
Surgery 110:303-310,1991 
18. Badger IL,Crosby HA,Kong KL,Baker JP,Hutchings ?,Elliott TSJ,McMaster P,Bion 
JF,Buckels JAC. Is selective decontamination of the digestive tract beneficial in liver 
transplant patients? Interim results of a prospective randomised triaL Transpi.Proceedings 
23:1460-1461 '1 991 
19. Cockerill FR,MuHer SR,Anhalt JP,Marsh HM,Farnell MB,Mucha P,Gmespie DJ,IIstrup 
OM,Larson-keHer JJ,Thompson RL. Prevention of infection in critica!ly itl patients by 
selective decontamination of the digestive tract. Ann.lntern.Med.117:545-553, 1992 
20. Rocha LA,Martin MJ,Pita S,Paz J,Seco C,Marqusino L,Villanueva R,Dur<::in MT. Prevention 
of nosocomial infections in critically ill patients by selective decontamination of the 
digestive tract. A randomised, double blind placebo controHed study. Intensive Care 
Med.18:398-404, 1992 
21. Cerra FB,Maddaus MA,Dunn DL,Wells CL,Konstantinides NN,Lehman SL,Mann HJ. 
Selective gut decontamination reduces nosocomial infections and length of stay but not 
mortality or organ failure in surgicat intensive care unit patients. Arch.Surg.127:163-
169,1992 
22. Brun-Buisson Ch,Legrand P,RaussA,Richard C,Montravers F,Besbes M,Meakins ML,Soussy 
CJ,Lemaire F. Intestinal decontamination for control of nosocomial multiresistant gram-
negative bacilli. Study of an outbreak in an intensive care unit. Ann.of lntern.Med.11 0:873-
881,1989 
23. Gastinne H,Wolff M,Delatour F,Faurisson F,Chevret S. A controlled trial in intensive care 
units of selective decontamination of the digestive tract with nonabsorbable antibiotics. 
N.Engi.J.Med.326:594-599, 1992 
24. Hammond JMJ,Potgieter PD,Saunders GL,Forder AA. Double-blind study of selective 
decontamination of the digestive tract in intensive care. Lancet 340:5-9,1992 
25. Knaus WA,Draper EA,Wagner OP,Zimmerman JE. APACHE II: a severity of disease 
classification system. Crit.Care Med.13:818-829, 1985 
26. Schardey M,Meyer G,Kern M,Marre R,Hohlbach G,Schildberg PN. Die nosokomiate 
lungeninfektion: praventive massnahmen beim chirurgischen intensivpatienten. lntensiv-
med.26:242-249, 1989 
27. Ledingham !McA,Eastaway AT,McKay IC,Alcock SR,McDonald JC, Ramsay G. Triple 
regimen of selective decontamination of the digestive tract, systemic cefotaxime and 
microbiological surveillance for prevention of acquired infection in intensive care. Lancet 
1:785-790,1988 
132 
28. Gross PA, van Antwerpen C. Nosocomial infections and hospital deaths. A case control 
study. Am.J.Med. 75:658-662,1983 
29. loirat Ph. Selective decontamination in intensive care unit patients. intensive Care 
Med.18:182-1 88,1992 
30. Liberati A,Brazzi L. Effect of selective decontamination of the digestive tract upon mortality. 
Rean.Urg.1(3 b;s):521·525, 1992 
31. Maschmever G,Haralambie E,Gaus W,Kern W,Dekker AW,de Vries·Hospers HG,Sizoo 
W,KOnig W,Gutzler F,Oaenen S. Ciprofloxacin and norfloxacin for selective decontamination 
in patients with severe granulocytopenia. Infection 1 6:98·1 03,1988 
32. Konrad F,Wiedeck H,Graf 8. Value of regular throat swab cultures with regard to antibiotic 
therapy in intubated patients with pneumonia and other infection [Abstract). Intensive Care 
Med.161Suppl. 1 I :32,1990 
33. Langer M,Mosconi P,Cigada M,Mande!li M. Long term respiratory support and risk of 
pneumonia in critically ill patients. Am.Rev.Respir.Dis.140:302·305, 1989 
34. Wiesner RH. The incidence of gram·negative bacterial and fungal infections in liver 
transplant patients treated with selective decontamination. infection 18($uppl. 1 ): 19~ 
21,1990 
35. Heimdahl A,Gahrton G,Groth CG,Lundgren G,L6nnquist B,Ringden O,Nord CE. Selective 
decontamination of alimentary tract microbial flora in patients treated with bone marrow 
transplantation. Scand.J.Infect.Dis.16:51~60, 1984 
Hoofdstuk 9 
AlGEMENE DISCUSSIE EN SAMENVATTING 

135 
9.1 lntroductie 
Levensondersteunendetechnieken op de Intensive Care Unit (ICU) zijn verantwoor-
delijk voor het toenemend aantal technisch moeilijke procedures bij steeds oudere 
patienten, maar kunnen voor diezelfde patient een ernstige bedreiging vormen door 
de aantasting van de afweer. Grote chirurgische ingrepen worden daarom 
vee!vuldig gecompliceerd door nosocomia!e infecties (infecties veroorzaakt door 
voornamelijk gram-negatieve ziekenhuisbacterien), die moeilijk te bestrijden zijn en 
een hoge mortaliteit veroorzaken (hoofdstuk 2). Om die red en hoort infectiepreven-
tie voHedig verweven te zijn met de intensive care geneeskunde. 
Tot op heden hebben aile maatregelen ter voorkoming van exogene 
besmetting zoals isolatie en infectiz preventie protocollen niet geresulteerd in een 
volledige preventie van infecties. De bevinding dat veel infecties ontstaan na 
endogene besmetting met bacterien uit de eigen tractus digestivus maakte de weg 
vrij voor preventie-programma's met behulp van antibiotica om dit endogene 
reservoir te ellmineren, maar deze resulteerden vaak in het ontstaan van resistente 
micro-organismen (hoofdstuk 3). 
Selectieve decontaminatie (SD) is een combinatie van enteraal in hoge 
doseringen gegeven, niet absorbeerbare antibiotica die werkzaam zijn tegen aerobe, 
gram-negatieve micro-organismen terwijl de anaerobe microflora zoveel mogefijk 
onaangetast blijft (hoofdstuk 3). In de oncologie is dit al lange tijd een geaccep-
teerde vorm van antibiotische profylaxe om het aantal koortsperioden in patienten 
met granulocytopenia te verminderen'. Het gebruik van deze profylaxe bij ernstig 
zieke patienten op de ICU kwam door de studie van Stoutenbeek en collega's in het 
middelpunt van de belangstelling te staan, omdat zij een sterke vermindering zag en 
van het aantal infecties in een groep polytrauma patienten'. Aangezien zij 
historische controles gebruikten, en met name het aantal luchtweginfecties pas 
verminderde na toevoeglng van parenterale antibiotica 3 werden in de tachtiger jaren 
andere studies opgezet om het effect van selectieve decontaminatie te onderzoe-
ken. Het grootste probleem was daarbij om goed vergelijkbare patientengroepen te 
vinden zodat een statistisch verantwoorde, gerandomiseerde studie kon worden 
opgezet, een probleem wat vooral groat is bij patienten in de intensive care unit. 
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De groep patienten met een slokdarmcarcinoom die op onze afdeling worden 
opgenomen om een resectie van de oesophagus met buismaagreconstructie te 
ondergaan hebben een groot risico om een luchtweginfectie te ontwikkelen 
(hoofdstuk 1 ). Omdat deze groep patienten zeer homogeen is, de patienten 
eenzelfde basisaandoening hebben en een gestandaardiseerd trauma ondergaan is 
deze groep bij uitstek geschikt om gerandomiseerd te bestuderen ten aanzien van 
de effecten van selectieve decontaminatie4 • Een bijkomend voordeel van de 
electieve ingreep is dat selectieve decontaminatie al pre-operatief kan worden 
geinstalleerd metals resultaat dat 93% van de patienten effectief gedecontami-
neerd bleek op de operatiedag (hoofdstuk 5). Als gevolg daarvan kunnen aile 
profylactische, parenterale antibiotica in deze patienten na de operatie gestaakt 
worden en dat is een gunstige ontwikkeling gezien het feit dat de ICU de afdeling 
is waar de meeste kans bestaat op ontstaan en verspreiding van resistentie tegen 
de gangbare antibiotica'"7 • Zelfs inclusief de profylactisch gebruikte antibiotica 
vertoonde de groep met effectieve decontaminatie een significante da!ing in het 
aantal dagen dat parenterale antibiotica gebruikt werden (hoofdstuk 6), en werd 
een 50% reductie gevonden van het aantal patienten die parenterale antibiotica 
therapeutisch nodig hadden (hoofdstuk 4), waardoor duidelijk is gemustreerd dat 
de antibiotische druk is verminderd. Er werd geen toename gevonden van resistente 
micro-organismen gedurende de 6 jaren van ervaring met deze profylaxe (hoofdstuk 
5 en 7). 
9.2 Seiectieve decontaminatie en morbiditeit 
De groep van Kerver8 was de eerste die een gerandomiseerde studie publiceerde 
over het gebruik van SD~medicatie in voornamelijk multitrauma patienten, en daarin 
een significante da!ing van luchtweginfecties, intra-abdominale abcessen en 
septische period en meldde. Wij vonden eveneens positieve effecten van selectieve 
decontaminatie bij patienten die grote, electief chirurgische procedures ondergaan 
(h0ofdstuk4l en tot op heden zijn ons 14 gerandomiseerde studies bekend4• .. 20 die 
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een significante da[ing van infecties in de studiegroep vinden; 5 daarvan waren 
dubbelblind, placebo gecontroleerd 11"13•16•20 (hoofdstuk 3). Aan de andere kant zijn 
er ook 4 studies die geen effect op infectiepercentages konden aantonen21 •24 , 
alhoewel Hammond en Gastinne beiden een daling van het aantal gram-negatieve 
infecties lieten zien23-24 . De afwezigheid van een effect is waarschijn!ijk dee!s te 
wijten aan de bestudeerde populatie, omdat 3 van deze 4 studies met name niet-
chirurgische patienten met interne aandoeningen als studiegroep gebruikten, terwijl 
de meeste studies met aantoonbaar effect van selectieve decontaminatie 
voorname!ijk chirurgische patienten bestudeerden. De vierde studie21 liet we! een 
daling van het aantal (gram-negatieve en -positieveJ infecties en het aantal 
geinfecteerde patienten zien. Deze da!ing was echter niet significant, wat mogelijk 
te wijten was aan hun kleine, heterogene groep chirurgische patienten. Deze 
heterogeniteit van patienten is met name van belang voor de vergelijkbaarheid van 
groepen wanneer patienten uit meerdere diagnostische categorieen samengevoegd 
worden, zeals in de studies van Hammond24 en Gastinne23 • Daarnaast was de 
studie van Gastinne23 een multicentrische studie met aHe nadelen van dien en was 
meer dan 40% van de patienten overgeplaatst uit andere centra, waardoor de 
vergelijkbaarheid van beide groepen nag extra in gevaar komt. Tot slot kregen beide 
groepen in de studie van Hammond24 voor niet minder dan 72 uur systemisch 
cefotaxime toegediend, wat mogelijke gevolgen heeft gehad voor de gemeten 
infectie percentages. Dit illustreert tevens dat het gebruikte schema altijd kritisch 
moet worden bekeken wanneer een nieuwe studie wordt gepresenteerd. Ondanks 
de tekortkomingen in de studie opzet van enkele studies, kan er een verschif 
bestaan tussen chirurgische en niet-chirurgische patienten waardoor de verschil-
lende effecten op infectie percentages ontstaan. 
De toename in gram-positieve colonisatie tijdens het gebruik van selectieve 
decontaminatie is tot op heden nog niet gevolgd door een toename in gram-
positieve infecties, behaive die gemeld in de studies van Gastinne en Hammond23-
24. Wanneer gram-positieve infecties ontstaan zijn deze echter makkefijk met de 
gang bare antibiotica te behandelen. 
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9.3 Selectieve decontaminatie en mortaliteit 
De effecten van selectieve decontaminatie op de mortaliteit komen nog niet zo 
overtuigend over als die op de morbiditeit (hoofdstuk 3). De enige studie die 
mortaliteit als eindpunt definieerde23 zag geen enkel effect van SD-medicatie maar 
had zoals vermeld in paragraaf 9.2 vele tekortkomingen. Rocha et al.20 rapporteer-
den een significante daling van de totale zowel als van de infectie gerelateerde 
mortaliteit maar meldden oak een toename van resistentie tegen cefotaxime en 
tobramycine. Blair17 stratificeerde zijn patientengroep vooraf naar APACHE II score, 
en zag een bijna significante daling van de mortaliteit in de groep met APACHE 
scores tussen de 10 en 19 (p = 0.07). Slechts een studie met historische 
controles25 en twee gerandomiseerde studies9·14 vermeldden een significante daiing 
van de mortaliteit. De resultaten in de eerste studie werden echter verstoord door 
het simultane gebruik van H2-blokkeerders en sucralfaat in verschillende subgroe-
pen25, en in de studie van U!rich9 werd colonisatie aileen in de studiegroep 
"behandeld" met antibiotica. Een aantal andere studies vonden een significante 
daling van de sterfte in subgroepen zoals chirurgische patienten met multitrauma26, 
infecties8 of sepsis9 , langdurig op de intensive care opgenomen patienten11 of 
patienten na cardiovasculaire chirurgie12 . Het is echter wei opvailend dat wanneer 
een gunstig effect wordt gerapporteerd, dit altijd in een chirurgische groep 
patienten blijkt op te treden. Effecten bij niet-chirurgische patienten zijn tot op 
heden nog niet aangetoond, mogelijk ten gevolge van hun onderliggend lijden en 
de invloed daarvan op de mortaliteit. Een effect van infectie preventie op de 
mortaliteit kan immers pas meetbaar worden (en dus van nut zijn) als de mortaliteit 
ten gevolge van het basislijden niet al te hoog is, zoals beschreven door Gross27• 
Waarom is het verschil in mortaliteit zo moeilijk aantoonbaar, terwijl, -de sterke 
relatie tussen infecties en mortaliteit inachtgenomen-, de effecten op infecties zo 
duidelijk zijn ? Om deze vraag op te lassen werd een vervolg studie gestart waarin 
aile patienten met SD-medicatie werden bestudeerd. In deze studie werd een groep 
patienten herkend die wei SD-medicatie kreeg toegediend, maar niet adequaat 
gedecontamineerd kon worden. Deze patienten hadden meer infecties, een hogere 
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mortaliteit en een langere opnameduur ten opzichte van patienten die vvel effectief 
gedecontamineerd konden worden (hoofdstuk 6). Wij denken dat deze subgroep 
waarbij effectieve decontaminatie niet kon worden verkregen verantwoordelijk kan 
zijn voor de onduidelijke effecten van selectieve decontaminatie op de sterfte 
binnen de gehele groep patienten. 
We realiseerden ons vooraf dat het moeilijk zou zijn voldoende grate 
aantal!en intensive care patienten met vergelijkbare aandoeningen te verzame!en 
om in een gerandomiseerde stu die een uitspraak te kunnen do en omtrent een effect 
van selectieve decontaminatie op de sterfte. Op de lnternationale Consensus 
Conferentie te Parijs" werd berekend dat minstens 2000 patienten per studie-arm 
nodig zouden zijn voordat een effect zou kunnen worden aangetoond, gegeven een 
basis mortaliteit van 30 tot 35% en een SO-effect van 10 tot 20%. Het is daarom 
interessant dat dit effect inderdaad werd aangetroffen in een meta-analyse van 
4000 patienten uit 22 gerandomiseerde studies". Om dit probleem van aantal en 
verscheidenheid van patienten te omzeilen besloten we aile patienten met SD-
medicatie te bestuderen, en te karakteriseren via de berekening van hun voorspelde 
sterftekans door mid del van de logistieke regressie formule van Knaus" (hoofdstuk 
6). Voor zover ons bekend is dit de beste formule om patienten te definieren voor 
wat betreft hun ""ernst van ziekte"", en kan deze gebruikt worden om effecten van 
nieuwe prophylactische of therapeutische programma's te bestuderen door de 
voorspelde percentages te vergelijken met de actuele. 
Het effect van selectieve decontaminatie op infectie- en sterfte cijfers was 
hoog significant in de groep patienten die goed gedecontamineerd kon worden 
(hoofdstuk 6). De subgroep van patienten die niet effectief gedecontamineerd 
kunnen worden (om wat voor red en dan oak), zijn mogelijk verantwoordelijk voor 
de tot op vandaag moeilijk te meten effecten van SD-prophylaxe op de sterfte. 
9.4 Se!ectieve decontaminatie, waar, hoe en voor wie 
Er is vee! discussie omtrent het ideale schema van selectieve decontaminatie omdat 
vee I studies verschillende antibiotica en verschillendecomponenten gebruikten, met 
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wisselend resultaat. De eerste studies gebruikten parenterale antibiotica om de 
patienten tegen vroege infecties te beschermen gedurende de tijd dat selectieve 
decontaminatie nag niet effectief was3 . Anderen meld den een significante daiing 
van het aanta! luchtweginfecties met oropharyngeale13 of enterale11 ·14 antibiotica 
aileen, echter zonder duidelijke informatie over het aantal gelnfecteerde patienten 13 
of het gebruik van parenterale antibiotica in de eerste dagen11 • 
Parenterale antibiotica 
Wij den ken dat parenterale antibiotica anders dan de routine chirurgische profylaxe 
op de operatiedag overbodig is voor patienten die electieve chirurgie ondergaan. 
Selectieve decontaminatie kan op zichzelf het aantal wondinfecties verlagen door 
vermindering van endogene colonisatie en daardoor van het aantal micro-
organismen en "besmettingsbronnen", maar kan nooit al!e wondinfecties 
voorkomen doordat de exogene route door deze profylaxe niet be"invloed kan 
worden. Tegen wondinfecties zijn peri-operatief gegeven antibiotica nodig die een 
adequate weefselspiegel geven ten tijde van de operatie; ofwel parenterale ofwel 
voor se!ectieve decontaminatie geschikte antibiotica die ook deels geresorbeerd 
worden zoals de quinolonen31 • Bij selectieve decontaminatie zijn parenterale 
antibiotics ens inziens aileen nodig in acuut opgenomen patienten die verdacht 
worden van een infectie gedurende de eerste dagen waarin SD nog niet effectief 
is. Konrad32 opperde dat bij kweken van PPM van een keelwat afgenomen bij 
opname systemische antibiotica gegeven zouden kunnen worden. 
Oropharyngea/e en Enterale antibiotica 
Het oropharyngeale deel van selectieve decontaminatie lijkt nodig om de opeenvol-
ging van oropharyngeale colonisatie en luchtweginfecties te kunnen voorkomen, 
de enterale component tegen wand- en urineweg infecties en mogelijk sepsis; 
tevens om de ontwikkeling van resistentie binnen het reservoir van micro-
organismen in de tractus digestivus te beperken. Ons inziens is het standaard 
gebruik van vancomycine zeals beschreven door Pugin16 niet aileen onwenselijk 
omdat gram-positieve infecties tot op heden goed te behandelen zijn, maar ook 
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gevaarlijk omdat resistentie ontwikkeling tegen dit middel een probleem op zou 
leveren bij de behandeling van de methicilline resistente Staphylococcus sp. 
Se!ectieve decontaminatie, wanneer 
Zoals bediscussieerd in hoofdstuk 4 en 6 is het wenselijk om SD-medicatie zo 
vroeg mogelijl< te starten om een effectieve selectieve decontaminatie te bereiken, 
omdat succesvol gedecontamineerde patienten het meeste voordeel hebben. Dit 
is in overeenstemming met Langer33 die stelde dat al!een maatrege!en genomen in 
de eerste dagen van opname de incidentie van nosocomiale luchtweginfecties op 
de ICU zou reduceren. SD-medicatie kan gestopt worden wanneer de afweerme-
chanismen tegen colonisatie en infectie weer zijn genormaliseerd (hoofdstuk 7), of 
wanneer de decontaminatie niet effectief blijkt. 
Surveillance kweken 
Surveillance kweken zijn een essentiee! dee! van selectieve decontaminatie, niet 
aileen om het ontstaan van eventuele resistentie tegen de gang bare antibiotica te 
onderkennen, maar tevens om te zien of patienten effectief gedecontamineerd zijn 
en om eventuele therapeutische interventies in de toekomst te bepalen. 
Selectieve decontaminatie, bij wie 
Welke patienten zullen voordeel hebben bij selectieve decontaminatie en moeten 
het daarom toegediend krijgen ? De positieve resultaten in de literatuur zijn meer 
uitgesproken bij chirurgische patienten; in een cross-over studie waren de 
resultaten binnen de chirurgische ICU beter dan die in de algemene ICU" en 
wanneer de sterfte als effectiviteits criterium wordt gebruikt Jijken a!leen 
chirurgische patienten een betere overleving te hebbene-e., 2 .14·17•26 • Multitrauma 
patienten en patienten met een langdurige ICU opname lijken voordeel te 
hebben9 '11 ' 14'26 , zowel als patienten na grate electieve chirurgie waarin de norma!e 
anatomie is veranderd (patienten met slokdarmcarcinoom4 ) of d'1e een verminderde 
afweer hebben door medicatie (levertransplantaties"·" en beenmergtransplan-
taties"l zodat gemakkelijk complicaties kunnen ontstaan. Het effect van selectieve 
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decontaminatie bij patienten met acuut necrotiserende pancreatitis wordt in een 
nationale multicentrische trial onderzocht. 
Kunnen we op de ICU opgenomen patienten die een verhoogd risico hebben 
op het ontwikkelen van infecties en daarom voordeel kunnen hebben van selectieve 
decontaminatie vooraf identificeren? Bij patienten met bekende risicofactoren 
(hoofdstuk 2) kan dit positief beantwoord worden, maar bij acuut opgenomen 
patienten is dat welhaast onmogelijk omdat het verdere klinische beloop onvoor-
spelbaar is. Zouden we tevens vooraf kunnen bepalen wie succesvol gedecontami-
neerd zou kunnen worden, dan zou dat een mogelijkheid bieden om vooraf te 
bepalen wie voordeel heeft van deze profylaxe en wie niet. Dat laatste zou een 
aanwijzing kunnen zijn dat de betreffende patient zo ernstig ziek is dat hij of zij op 
geen enkele therapie meer zal reageren. Een verdere analyse zal mogelijke 
risicofactoren voor onsuccesvolle decontaminatie aan kunnen geven en ons dus een 
handvat geven voor de preventie van falende selectieve decontaminatie, of ons een 
predictor van overleving aan de hand doen. 
9.5 Conclusie 
Selectieve decontaminatie is een veilige methode om gram-negatieve co!onisatie 
en infecties te voorkomen bij ernstig zieke patienten die grote, electief chirurgische 
procedures ondergaan. Het is wenselijk SD-medicatie zo vroeg mogelijk te starten 
in goed gedefinieerde patienten groepen die een groat risico hebben op het 
ontwikkeien van gram-negatieve infecties op basis van preexistente risicofactoren 
of als gevolg van de geplande operatie. SD-medicatie kan 5 dagen na extubatie 
gestaakt worden wanneer de colonisatie resistentie zich heeft genormaliseerd, en 
lijkt van geen nut wanneer een paging tot effectieve decontaminatie geen succes 
heeft gehad. De periode van 5 dagen is op klinische gronden gekozen en lijkt te 
voldoen. Wanneer succesvolle selectieve decontaminatie kan worden bereikt is dat 
van groat voordeel voor de patient gezien de effecten op morbiditeit en overleving, 
voor het ziekenhuis omdat het gebruik van parenterale antibiotica significant lager 
is en voor de gemeenschap omdat de opnameduur korter is en de kosten verwacht 
kunnen worden te dalen. 
143 
9.6 References 
1. Furth R van,Guiot HFL. Modulation of the host flora. Eur.J.Ciin.Microbiol.lnfect.Dis.8:1-
7, 1989 
2. Stoutenbeek ChP,van Saene HKF,Miranda DR,Zandstra OF. The effect of selective 
decontamination of the digestive tract on colonization and infection rate in multiple trauma 
patients. Intensive Care Med.1 0:185-192,1984 
3. Stoutenbeek ChP,van Saene HKF,Miranda DR,Zandstra DF.Langrehr D. The effect of 
oropharyngeal decontamination using topical nonabsorbabte antibiotics on the incidence of 
nosocomial respiratory tract infections in multiple trauma patients. J.Trauma 27:357-
364,1987 
4. Tetteroo GWM,Wagenvoort JHT,Castelein A,Tilanus HW,Ince C,Bruining HA. Selective 
decontamination to reduce gram-negative colonisation and infections after oesophageal 
resection. Lancet 335:704-707,1990 
5. Maki DG. Risk factors for nosocomial infection in intensive care. Devices vs nature and 
goals for the next decade [commentary]. Arch.lntern.Med.149:30-35, 1989 
6. Milatovic D,Braveny I. Development of resistance during antibiotic therapy. Eur.J.Clin. 
Microbiol.6:234-244, 1987 
7. Waay D van der. Colonisation resistance of the digestive tract: clinical consequences and 
implications. J.Antimicrob.Chemother.1 0:263-270,1982 
8. Kerver AJH,Rommes JH,Mevissen-Verhage EAE,Hulstaert PF,Vos A, Verhoef J,Wittebol P. 
Prevention of colonization and infection in critically ill patients, a prospective randomised 
study. Crit.Care Med.16:1 087·1093, 1988 
9. Ulrich C,Harinck-de Weerd,Bakker NC,Jacz K,Doornbos L,de Ridder VA. Selective 
decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired 
infections: a prospective randomised study. Intensive Care Med.15:424-431,1989 
10. Aerdts SJA. Prevention of lower respiratory tract infection in mechanically ventilated 
patients. [Thesis], 1989,State University Maastricht, The Netherlands. 
11. Godard J,GuiHaume C,Reverdy M-E, Bachmann P,Bui-Xuan B,Nageotte A,Motin J.lntestinat 
decontamination in a polyvalent ICU. A double-blind study. Intensive Care Med.16:307-
311,1990 
12. Hartenauer U,Thulig B,lawin P,FegelerW. Infection surveillance and selective decontamina-
tion of the digestive tract {$00) in critically ill patients. Results of a controlled study. 
Infection 18 (Suppl.1 ):22-30, 1990 
13. Rodriguez-Roldan JM,Altuna-Cuesta A,Lopez A,Carillo A,Garcia J,leon J,Martinez-Pellus 
AJ. Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial 
pharyngeal nonabsorbable paste. Crit.Care Med.18:1239-1242,1990 
14. HUnefeld G.von. Klinische studie zur selektiven darmdekolonisation bei 204 !angzeitbeatme-
ten abdominal- und unfallchirurgischen intensivpatienten. Anaesthesioi.Reanimat.14:131-
153, 1989 
144 
15. Unert! K,Ruckdeschel G,Selbmann HK,Jensen U,Forst H,Lenhart FP,Peter K. Prevention of 
colonisation and respiratory tract infections in long-term ventilated patients by local an-
timicrobial prophylaxis. lntensive Gare Med.13:1 06-113,1987 
16. Pugin J,Auckenthaler R,Lew OP,Suter PM. Oropharyngeal decontamination decreases 
incidence of ventilator associated pneumonia. A randomised, placebo controlled, double 
blind clinical trial. JAMA 265:2704-2710,1991 
17. Blair ?,Rowlands BJ,Lowry K,Webb H,Armstrong ?,Smilie J. Selective decontamination of 
the digestive tract: a stratified randomised prospective study in a mixed intensive care unit. 
Surgery 11 0:303·31 0,1991 
18. Badger ll,Crosby HA,Kong Kl,Saker JP,Hutchings P,Eiliott TSJ,McMaster P,Bion 
JF,Buckels JAC. Is selective decontamination of the digestive tract beneficial in liver 
transplant patients? Interim results of a prospective randomised trial. Transpi.Proceedings 
23:1460·1461 '1 991 
19. Cockerill FR,Muller SR,Anhalt JP,Marsh HM,Farnell MB,Mucha ?,Gillespie DJ,IIstrup 
DM,Larson-kelier JJ,Thompson Rl. Prevention of infection in critically ill patients by selee> 
tive decontamination of the digestive tract. Ann.lntern.Med.117:545-553, 1992 
20. Rocha la,Martin MJ,Pita S,Paz J,Seco C,Marqusino L,Villanueva R,Duran MT. Prevention 
of nosocomial infections in critically ill patients by selective decontamination of the 
digestive tract. A randomised, double blind placebo controlled study. Intensive Care 
Med.18:398-404, 1992 
21. Cerra FB,Maddaus MA,Dunn DL,Wells Cl,Konstantinides NN,Lehman SL,Mann HJ. 
Selective gut decontamination reduces nosocomial infections and length of stay but not 
mortality or organ failure in surgical intensive care unit patients. Arch.Surg.127:163-
169,1992 
22. Brun-Buisson Ch,Legrand P,RaussA,Richard C,Montravers F,Besbes M,Meakins Ml,Soussy 
CJ,lemaire F. Intestinal decontamination for control of nosocomial multiresistant gram-
negative bacilli. Study of an outbreak in an intensive care unit. Ann.of lntern.Med.11 0:873-
881,1989 
23. Gastinne H,Wolff M,Delatour F,Faurisson F,Chevret S. A controlled trial in intensive care 
units of selective decontamination of the digestive tract with nonabsorbable antibiotics. 
N.Engi.J.Med.326:594·599, 1992 
24. Hammond JMJ,Potgieter PD,Saunders GL,Forder AA. Double-blind study of selective 
decontamination of the digestive tract in intensive care. lancet 340:5-9,1992 
25. Schardey M,Meyer G,Kern M,Marre R,Hohlbach G,Schildberg FW. Die nosokomiale 
lungeninfektion: praventive massnahmen beim chirurgischen intensivpatienten. inten-
sivmed.26:242·249, 1989 
26. Ledingham IMcA,Eastaway AT,McKay IC,Aicock SR,McDonald JC, Ramsay G. Triple 
regimen of selective decontamination of the digestive tract, systemic cefotaxime and 
microbiological surveillance for prevention of acquired infection in intensive care. Lancet 
1:785-790,1988 
27. Gross PA,van Antwerpen C. Nosocomial infections and hospital deaths. A case contra! 
study. Am.J.Med. 75:658-662,1983 
145 
28. Loirat Ph. Selective decontamination in intensive care unit patients. Intensive Care 
Med.18:182-188, 1992 
29. Liberati A, Brazzi L. Effect of selective decontamination of the digestive tract upon mortality. 
R~an.Urg.113 bis):521-525, 1992 
30. Knaus WA,Draper EA,Wagner DP,Zimmerman JE. APACHE II: a severity of disease 
classification system. Crit.Care Med.13:818-829, 1985 
31. Maschmeyer G,Haralambie E,Gaus W,Kern W,Dekker AW,de Vries-Hospers HG,Sizoo 
W,KOnig W,Gutzler F,Daenen S. Ciprofloxacin and norf!oxacin for selective decontamination 
in patients with severe granulocytopenia. Infection 16:98-103,1988 
32. Konrad F, Wiedeck H,Graf B. Value of regular throat swab cultures with regard to antibiotic 
therapy in intubated patients with pneumonia and other infection {Abstract]. tntensive Care 
Med.161Suppl.1):32, 1990 
33. Langer M,Mosconi P,Cigada M,Mandelli M. long term respiratory support and risk of 
pneumonia in critically ill patients. Am.Rev.Respir.Dis.140:302-305, 1989 
34. Wiesner RH. The incidence of gram-negative bacterial and fungal infections in fiver 
transplant patients treated with selective decontamination. Infection 18{Suppl.1 ):19-
21,1990 
35. Heimdahl A.Gahrton G,Groth CG,lundgren G,LOnnquist B,Ringden O,Nord CE. Selective 
decontamination of alimentary tract microbia! flora in patients treated with bone marrow 
transplantation. Scand.J.Infect.Dis. 1 6:51-60,1984 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
147 
Dankwoorcl 
Aan de totstanclkoming van dit proefschrift hebben velen bijgedragen. Allereerst 
mijn ouders, die mij de noodzakelijke volharding en doorzettingsvermogen hebben 
bijgebracht. Helaas kreeg mijn vader niet de tijd om dat wat hij heeft uitgedragen 
te kunnen herkennen in zijn kinderen. Prof.dr. HA Bruining, mijn promotor en 
opleider, staat aan de basis van mijn chirurgische loopbaan en heeft mij in een 
vroeg stadium weten te interesseren voor de dynamiek in de intensive care 
geneeskunde. Een man van weinig woorden, maar alom aanwezig. Dr. JHT 
Wagenvoort, mijn co-promotor heeft mij zeker in het prille begin vee! microbiologi-
sche begrippen en principes bijgebracht. Allard Castelein deed vee! voorbereidend 
werk en stame de eerste klinische trial op. Dr. JW Merkelbach, Dr. SG Looyen en 
Dr. KJ Brouwer, opleider en stafleden van het Bergweg Ziekenhuis gaven mij de 
mogelijkheid om gedurende mijn "perifere" jaren het klinische onderzoek binnen 
Dijkzigt te blijven verrichten. Ook de stimulerende omgeving heb ik zeer weten te 
waarderen. Prof.dr. JWM van der Meer, Prof.dr. MF Michel en Dr.lr. C lnce dank 
ik voor hun bereidheid het manuscript te beoordelen. Prof.dr. !MeA ledingham en 
Prof.dr. D van der Waay dank ik veer hun welwillendheid om zitting te nemen in 
de promotiecommissie. Paul Mulder zorgde voor de statistische verwerking van de 
gegevens. 
Een enorme hoeveelheid werk is verricht door de verpleegkundigen van de 
chirurgische intensive care en de chirurgische verpleegafdelingen, en laboranten 
van het bacteriologisch laboratorium. Dit onderzoek betekende veel extra werk 
waarvoorvelen zich ingezet hebben. Zender iemand tekort te will en do en wil ik met 
name Jan, Willem, Carla en Henny noemen die een groot deel van de kweken en 
administratie in goede banen leidden. Veel dank is ook verschuldigd aan de vele 
collegae assistenten, zonder wiens hulp een klinische studie niet te volbrengen is, 
maar ik wil vooral Maarten Meyssen, Marieke Menu en Ernest Luyten noemen voor 
de begeleiding van de trial tijdens mijn afwezigheid. 
148 
Koert de Jong en Olivier Busch dank ik voor hun steun als paranimf. 
Vrienden, ernstig veronachtzaamt, bedank ik voor hun geduld. De banden kunnen 
weer aangehaald. 
Tot slot weet Annelies als geen ander wat noodzakelijk is voordat het een 
en ander op papier staat. Het tekent je dat "thuis" (vrijwel) altijd een rustpunt 
bleek, en dat je mij wanneer nodig het vertrouwen kon Iaten hervinden. 
149 
Curriculum vitae 
De auteur werd op 28 juli 1959 geboren te Naaldwijk. Hij bezocht het Lodewijk 
Makeblijde College te Rijswijk !ZH), behaalde het VWO diploma (Atheneum B) in 
1978 en studeerde vanwege de numerus fix us het daarop volgende jaar scheikunde 
aan de Rijks Universiteit Leiden. Vanaf 1979 volgde hij de studie geneeskunde aan 
de Erasmus Universiteit te Rotterdam, waar op 7 augustus 1984 het 
doctoraalexamen en op 21 februari 1986 het artsexamen werd behaald. Vanafapril 
1986 werkte hij als assistent geneeskundige niet in opleiding (AGNIO) op de 
afdeling heelkunde van het Academisch Ziekenhuis Dijkzigt te Rotterdam (hoofd: 
Prof.dr.Hvan Houten t) waaronder Ieiding van Prof.dr.HA Bruining begonnen werd 
met het onderzoek wat ten grondslag ligt aan dit proefschrift. Per 1 mei 1988 
begon de opleiding tot chirurg in het Bergweg Ziekenhuis te Rotterdam (opleider: 
Dr.JW Merkel bach), per september 1990 voortgezet in het Academisch Ziekenhuis 
Dijkzigt te Rotterdam (hoofd: Prof.dr.J Jeekel; opleider: Prof.dr.HA Bruining). In 
december 1991 ontving hij de "Schoemakerprijs 1990" van de Nederlandse 
Vereniging voor Heelkunde. Registratie als chirurg zal in het voorjaar van 1994 
vo!gen. De auteur is getrouwd en heeft een zoon. 



